Tronox (TROX) 10-Q 9 Nov 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 27, 2017
Document Information [Line Items]
Entity Registrant Name	Tronox Ltd
Entity Central Index Key	1,530,804
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Class A Ordinary Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		91,052,581
Class B Ordinary Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		28,729,280

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]
Net sales		$ 435	$ 339	$ 1,234	$ 957
Cost of goods sold		329	291	971	877
Gross profit		106	48	263	80
Selling, general and administrative expenses		(55)	(47)	(186)	(135)
Restructuring income (expense)		0	(1)	1	(2)
Income (loss) from operations		51	0	78	(57)
Interest and debt expense, net		(47)	(46)	(140)	(138)
Gain (loss) on extinguishment of debt		(28)	0	(28)	4
Other income (expense), net		12	(10)	5	(22)
Income (loss) from continuing operations before income taxes		(12)	(56)	(85)	(213)
Income tax provision		(13)	(6)	(10)	(25)
Net income (loss) from continuing operations		(25)	(62)	(95)	(238)
Income (loss) from discontinued operations, net of tax (See Note 2)		(216)	23	(179)	55
Net income (loss)		(241)	(39)	(274)	(183)
Net income (loss) attributable to noncontrolling interest		6	(2)	11	(1)
Net income (loss) attributable to Tronox Limited		$ (247)	$ (37)	$ (285)	$ (182)
Net income (loss) per share, basic and diluted:
Continuing operations (in dollars per share)	[1]	$ (0.26)	$ (0.53)	$ (0.89)	$ (2.04)
Discontinued operations (in dollars per share)	[1]	(1.81)	0.20	(1.51)	0.47
Net income (loss) per share, basic and diluted (in dollars per share)	[1]	$ (2.07)	$ (0.33)	$ (2.40)	$ (1.57)
Weighted average shares outstanding, basic and diluted (in shares)		119,405	116,219	118,908	116,108
[1]	Loss per ordinary share amounts were calculated from exact, not rounded, loss and share information.

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) [Abstract]
Net income (loss)	$ (241)	$ (39)	$ (274)	$ (183)
Other comprehensive income:
Foreign currency translation adjustments	(36)	69	22	122
Pension and postretirement plans:
Actuarial losses, (no tax impact; See Note 3)	0	(21)	0	(21)
Amortization of unrecognized actuarial losses, net of taxes of less than $1 million in each of the three and nine months ended September 30, 2017 and 2016	1	(1)	2	0
Impact of transfer of Alkali pension obligation upon sale (no tax impact)	5	0	5	0
Unrealized gains (losses) on derivative financial instruments (no tax impact; see Note 3)	0	(1)	(3)	1
Other comprehensive income (loss)	(30)	46	26	102
Total comprehensive income (loss)	(271)	7	(248)	(81)
Comprehensive income (loss) attributable to noncontrolling interest:
Net income (loss)	6	(2)	11	(1)
Foreign currency translation adjustments	(10)	18	3	31
Comprehensive income (loss) attributable to noncontrolling interest	(4)	16	14	30
Comprehensive income (loss) attributable to Tronox Limited	$ (267)	$ (9)	$ (262)	$ (111)

CONDENSED CONSOLIDATED STATEME4

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Maximum [Member]
Pension and postretirement plans:
Amortization of unrecognized actuarial losses, taxes	$ 1	$ 1	$ 1	$ 1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions		Sep. 30, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents		$ 1,058	$ 248
Restricted cash		653	3
Accounts receivable, net of allowance for doubtful accounts		309	278
Inventories, net		459	499
Prepaid and other assets		44	28
Income taxes receivable		1	11
Total assets of discontinued operations		0	1,671
Total current assets		2,524	2,738
Noncurrent Assets
Property, plant and equipment, net	[1]	1,069	1,092
Mineral leaseholds, net		859	877
Intangible assets, net		203	223
Inventories, net		14	14
Other long-term assets		22	20
Total assets		4,691	4,964
Current Liabilities
Accounts payable		155	136
Accrued liabilities		131	150
Short-term debt		0	150
Long-term debt due within one year		11	16
Income taxes payable		2	1
Total liabilities of discontinued operations		0	111
Total current liabilities		299	564
Noncurrent Liabilities
Long-term debt, net		3,129	2,888
Pension and postretirement healthcare benefits		100	114
Asset retirement obligations		78	73
Long-term deferred tax liabilities		161	151
Other long-term liabilities		18	21
Total liabilities		3,785	3,811
Commitments and Contingencies
Shareholders' Equity
Capital in excess of par value		1,542	1,524
Accumulated deficit		(321)	(19)
Accumulated other comprehensive loss		(474)	(497)
Total Tronox Limited shareholders' equity		748	1,009
Noncontrolling interest		158	144
Total equity		906	1,153
Total liabilities and equity		4,691	4,964
Class A Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares		1	1
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares		$ 0	$ 0
[1]	Substantially all of these assets are pledged as collateral for our debt. See Note 11.

CONDENSED CONSOLIDATED BALANCE6

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Class A Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.01	$ 0.01
Ordinary shares, shares issued (in shares)	68,767,566	65,998,306
Ordinary shares, shares outstanding (in shares)	68,591,094	65,165,672
Class B Ordinary Shares [Member]
Shareholders' Equity
Ordinary shares, par value (in dollars per share)	$ 0.01	$ 0.01
Ordinary shares, shares issued (in shares)	51,154,280	51,154,280
Ordinary shares, shares outstanding (in shares)	51,154,280	51,154,280

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities:
Net income (loss)	$ (274)	$ (183)
Income (loss) from discontinued operations, net of tax	(179)	55
Net income (loss) from continuing operations	(95)	(238)
Adjustments to reconcile net loss from continuing operations to net cash provided by operating activities, continuing operations:
Depreciation, depletion and amortization	136	131
Deferred income taxes	8	(5)
Share-based compensation expense	26	18
Amortization of deferred debt issuance costs and discount on debt	9	8
Pension and postretirement healthcare benefit expense	2	0
(Gain) loss on extinguishment of debt	28	(4)
Other, net	22	35
Contributions to employee pension and postretirement plans	(18)	(15)
Changes in assets and liabilities:
(Increase) decrease in accounts receivable, net	(29)	(3)
(Increase) decrease in inventories, net	48	94
(Increase) decrease in prepaid and other assets	(16)	(3)
Increase (decrease) in accounts payable and accrued liabilities	(27)	(33)
Increase (decrease) in taxes payable	0	28
Cash provided by operating activities, continuing operations	94	13
Cash Flows from Investing Activities:
Capital expenditures	(63)	(59)
Debt proceeds restricted for Cristal acquisition	(650)	0
Proceeds from sale of business	1,325	0
Proceeds from the sale of assets	0	1
Cash provided by (used in) investing activities, continuing operations	612	(58)
Cash Flows from Financing Activities:
Repayments of long-term debt	(2,342)	(27)
Repayments of short-term debt	(150)	0
Proceeds from long-term debt	2,589	0
Debt issuance costs	(36)	0
Call premium paid	(14)	0
Proceeds from options and warrants	1	0
Dividends paid	(17)	(40)
Restricted stock and performance-based shares settled in cash for taxes	(11)	(1)
Cash provided by (used in) financing activities, continuing operations	20	(68)
Discontinued Operations:
Cash provided by operating activities	107	112
Cash used in investing activities	(25)	(29)
Cash used in financing activities	0	0
Net cash flows provided by discontinued operations	82	83
Effects of exchange rate changes on cash and cash equivalents	2	3
Net increase (decrease) in cash and cash equivalents	810	(27)
Cash and cash equivalents at beginning of period	248	229
Cash and cash equivalents at end of period, continuing operations	$ 1,058	$ 202

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENT OF EQUITY (Unaudited) - USD ($) $ in Millions	Total Tronox Limited Shareholders' Equity [Member]	Tronox Limited Ordinary Shares [Member]Class A Ordinary Shares [Member]	Tronox Limited Ordinary Shares [Member]Class B Ordinary Shares [Member]	Capital in Excess of par Value [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2015						$ (598)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)								$ (183)
Other comprehensive income								102
Balance at Sep. 30, 2016						(527)
Balance at Jun. 30, 2016						(555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)								(39)
Other comprehensive income								46
Class A and Class B share dividends								(5)
Balance at Sep. 30, 2016						(527)
Balance at Dec. 31, 2016	$ 1,009	$ 1	$ 0	$ 1,524	$ (19)	(497)	$ 144	1,153
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(285)	0	0	0	(285)	0	11	(274)
Other comprehensive income	23	0	0	0	0	23	3	26
Share-based compensation	28	0	0	28	0	0	0	28
Shares cancelled	(11)	0	0	(11)	0	0	0	(11)
Shares and warrants exercised	1	0	0	1	0	0	0	1
Class A and Class B share dividends	(17)	0	0	0	(17)	0	0	(17)
Balance at Sep. 30, 2017	748	1	0	1,542	(321)	(474)	158	906
Balance at Jun. 30, 2017						(454)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)								(241)
Other comprehensive income								(30)
Class A and Class B share dividends								(5)
Balance at Sep. 30, 2017	$ 748	$ 1	$ 0	$ 1,542	$ (321)	$ (474)	$ 158	$ 906

The Company

The Company	9 Months Ended
	Sep. 30, 2017
The Company [Abstract]
The Company	1. The Company Tronox Limited and its subsidiaries (collectively referred to as “Tronox Limited,” “we,” “us,” or “our”) is a public limited company registered under the laws of the State of Western Australia. We are a global leader with operations in North America, Europe, South Africa and the Asia-Pacific region in the production and marketing of titanium bearing mineral sands and titanium dioxide (“TiO 2 TiO 2 On February 21, 2017, Tronox Limited, The National Titanium Dioxide Company Ltd., a limited company organized under the laws of the Kingdom of Saudi Arabia (“Cristal”), and Cristal Inorganic Chemicals Netherlands Coöperatief W.A., a cooperative organized under the laws of the Netherlands and a wholly owned subsidiary of Cristal (“Seller”), entered into a Transaction Agreement (the “Transaction Agreement”), pursuant to which we agreed to acquire Cristal’s titanium dioxide business for $1.673 billion in cash, subject to a working capital adjustment at closing (the “Cash Consideration”), plus 37,580,000 Class A ordinary shares (“Class A Shares”), par value $0.01 per share, of Tronox Limited (the “Cristal Transaction”). Following the closing of the Cristal Transaction, the Seller will own approximately 24% of the outstanding ordinary shares (including both Class A and Class B) of Tronox Limited. The Cristal Transaction is conditioned on us obtaining financing sufficient to fund the Cash Consideration, and the Transaction Agreement provides that we must pay to Cristal a termination fee of $100 million if all conditions to closing, other than the financing condition, have been satisfied and the Transaction Agreement is terminated because closing of the Cristal Transaction has not occurred by May 21, 2018. As a result of the refinancing (See Note 11 - Debt), we expect to finance the Cristal Transaction with our cash on hand inclusive of restricted cash and liquidity from our asset-based syndicated revolving credit facility. The Cristal Transaction is also conditioned upon the receipt of various regulatory approvals, including antitrust clearance in numerous jurisdictions. On April 13, 2017, the United States Federal Trade Commission (“FTC”) issued a request for additional information (“Second Request”) to us and Cristal in connection with its filing under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and Tronox has substantially complied with the Second Request. The Cristal Transaction, which has been unanimously approved by our board of directors (the “Board”), is expected to close by the first quarter of 2018, subject to regulatory approvals and satisfaction of customary closing conditions. On October 2, 2017, at a special meeting of shareholders of the Company held pursuant to the Transaction Agreement, the Company’s shareholders approved a resolution to issue 37,580,000 Class A Shares to the Seller in connection with the acquisition of Cristal’s TiO 2 On September 1, 2017, we completed the previously announced sale of our wholly owned subsidiary Tronox Alkali Corporation (“Alkali”) to Genesis Energy, L.P. for proceeds of $1.325 billion in cash, subject to a customary post-closing working capital adjustment (the “Sale”). Energy, L.P During the three months ended September 30, 2017, we recognized a pre-tax loss of $233 million on the Alkali disposal. For all periods presented, sales, costs and expenses and income taxes attributable to Alkali together with the loss on disposal have been aggregated in a single caption entitled “Income (loss) from discontinued operations, net of tax” in our Condensed Consolidated Statement of Operations. Included in the calculation of the loss noted above, were approximately $21 million of transaction fees related to the sale of Alkali. For cash flow presentation purposes, these transaction costs are included in “Cash provided by operating activities, continuing operations” on the Condensed Consolidated Statements of Cash Flows. See Note 2 – Discontinued Operations for additional information. In 2012, our Class B ordinary shares (“Class B Shares”) were issued to Exxaro Resources Limited (“Exxaro”) and one of its subsidiaries in consideration for 74% of Exxaro’s South African mineral sands business. Exxaro has agreed not to acquire any voting shares of Tronox Limited if, following such acquisition, Exxaro will have a voting interest in Tronox Limited of 50% or more unless Exxaro brings any proposal to make such an acquisition to the Board on a confidential basis. In the event an agreement regarding the proposal is not reached, Exxaro is permitted to make a takeover offer for all the shares of Tronox Limited not held by affiliates of Exxaro, subject to certain non-waivable conditions. At September 30, 2017 and December 31, 2016, Exxaro held approximately 43% and 44%, respectively, of the voting securities of Tronox Limited. See Note 18 for additional information regarding Exxaro transactions. On March 8, 2017, Exxaro announced its intention to begin pursuing a path to monetize its ownership stake in Tronox over time. On October 10, 2017, Exxaro sold 22,425,000 Class A ordinary shares in an underwritten registered offering (the “Exxaro Share Transaction”). Subsequent to the Exxaro Shares Transaction, Exxaro held approximately 24% of the Company’s voting securities. Presently, Exxaro intends to sell the remainder of its Tronox shares in a staged process over time pursuant to the existing registration statement, subject to market conditions. Exxaro’s sale of Class A ordinary shares does not impact their 26% ownership interest in each of our Tronox KZN Sands (Pty) Ltd. and Tronox Mineral Sands (Pty) Ltd subsidiaries. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited, and have been prepared pursuant to the rules and regulations of the U. S. Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016. The Condensed Consolidated Balance Sheet as of December 31, 2016 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, considered necessary for a fair statement. Our unaudited condensed consolidated financial statements include the accounts of all majority-owned subsidiary companies. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the manner and presentation in the current period. As a result of the Alkali disposition, the results of Alkali have been reclassified as discontinued operations for all periods presented. See Note 2 – Discontinued Operations for additional information. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that the effect on the financial statements of a change in estimate due to one or more future confirming events could have a material effect on the financial statements. Revision of Previously Issued Consolidated Financial Statements During the three months ended March 31, 2017, we identified a misstatement in our selling, general, and administrative expense for certain prior periods related to a liability resulting from a non-timely filing with a statutory authority. The aggregate misstatement is $11 million, which impacts our previously issued consolidated statements of operations, comprehensive loss, balance sheets and cash flows as of and for the years ended December 31, 2015 and 2016, and the unaudited condensed consolidated financial statements for the third and fourth quarters and corresponding year-to-date periods of 2015, and each quarter and corresponding year-to-date periods of 2016. In accordance with Staff Accounting Bulletin (“SAB”) No. 99, Materiality Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements The effects on our unaudited condensed consolidated financial statements are as follows: Unaudited Condensed Consolidated Statement of Operations Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported (1) Adjustment Revised As Reported (1) Adjustment Revised Net sales $ 339 $ — $ 339 $ 957 $ — $ 957 Cost of goods sold 290 1 291 877 — 877 Gross profit 49 (1 ) 48 80 — 80 Selling, general and administrative expenses (47 ) — (47 ) (131 ) (4 ) (135 ) Income (loss) from operations 1 (1 ) — (53 ) (4 ) (57 ) Other income (expense), net (13 ) 3 (10 ) (22 ) — (22 ) Income (loss) from continuing operations before income taxes (58 ) 2 (56 ) (209 ) (4 ) (213 ) Net income (loss) from continuing operations (64 ) 2 (62 ) (235 ) (3 ) (238 ) Income (loss) from discontinued operations, net of tax 22 1 23 53 2 55 Net loss attributable to Tronox Limited (40 ) 3 (37 ) (181 ) (1 ) (182 ) Net income (loss) per share from continuing operations, basic and diluted (0.54 ) 0.01 (0.53 ) (2.02 ) (0.02 ) (2.04 ) Net income (loss) per share from discontinued operations, basic and diluted 0.19 0.01 0.20 0.46 0.01 0.47 Weighted average shares outstanding, basic and diluted (in thousands) 116,219 116,219 116,219 116,108 116,108 116,108 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported Adjustment Revised As Reported Adjustment Revised Net loss $ (42 ) $ 3 $ (39 ) $ (182 ) $ (1 ) $ (183 ) Total comprehensive income ( loss) 4 3 7 (80 ) (1 ) (81 ) Comprehensive loss attributable to Tronox Limited (12 ) 3 (9 ) (110 ) (1 ) (111 ) Unaudited Condensed Consolidated Balance Sheet December 31, 2016 As Reported (1) Adjustment Revised Current assets of continuing operations $ 1,067 $ — $ 1,067 Total assets of discontinued operations 1,668 3 1,671 Total current assets 2,735 3 2,738 Total assets 4,961 3 4,964 Accrued liabilities 138 11 149 Current liabilities of continuing operations 443 10 453 Total liabilities of discontinued operations 110 1 111 Total current liabilities 553 11 564 Total liabilities 3,800 11 3,811 Accumulated deficit (13 ) (6 ) (19 ) Accumulated other comprehensive loss (495 ) (2 ) (497 ) Total Tronox Limited shareholders’ equity 1,017 (8 ) 1,009 Total equity 1,161 (8 ) 1,153 Total liabilities and equity 4,961 3 4,964 (1) Amounts reflect the results of Alkali as discontinued operations. Unaudited Condensed Consolidated Statement of Cash Flows There was no net impact to operating, investing and financing cash flows from the revisions for continuing operations for the nine months ended September 30, 2016. Adopted Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Improvements to Employee Share-Based Payment Accounting Compensation – Stock Compensation In March 2016, the FASB issued ASU 2016-05, Derivatives and Hedging: Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships Derivatives and Hedging In July 2015, as part of its simplification initiative, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory Recently Issued Accounting Pronouncements We consider the applicability and impact of all recently issued ASUs. Those not listed below were assessed and determined to be either not applicable or expected to have a minimal impact on our consolidated financial statements. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities In May 2017, the FASB issued ASU 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting In March 2017, the FASB issued ASU 2017-07, Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230) In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, the FASB issued ASU 2016-02, Leases In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606)

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2017
Discontinued Operations [Abstract]
Discontinued Operations	2. Discontinued Operations Concurrent with the announcement of the Cristal Transaction, we expressed intent to begin a process to market our Alkali soda ash business which met the criteria as held for sale in the third quarter and was sold on September 1, 2017. The sale of Alkali is an important step in positioning us as a global leader in the titanium dioxide (TiO 2 Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity Alkali, which was previously one of our two operating and reportable segments, included certain allocated corporate costs which have been reallocated to Corporate. The amount of allocated corporate costs was $1 million and $3 million, respectively, for each of the three and nine months ended September 30, 2017 and 2016. After the sale, we now operate in a single operating and reportable segment, TiO 2 The following table presents the major classes of Alkali’s line items constituting the “Income (loss) from discontinued operations, net of tax” in our Condensed Consolidated Statements of Operations: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net sales $ 129 $ 194 $ 521 $ 590 Cost of goods sold 113 163 448 511 Selling, general and administrative expenses (6 ) (7 ) (18 ) (20 ) Income before income taxes 10 24 55 59 Income tax benefit (provision) 7 (1 ) (1 ) (4 ) Loss on sale of discontinued operations, no tax impact (233 ) — (233 ) — Income (loss) from discontinued operations $ (216 ) $ 23 $ (179 ) $ 55 The following table is a summary of the carrying amounts of Alkali’s assets and liabilities included as “Total assets of discontinued operations” and “Total liabilities of discontinued operations” of December 31, 2016: December 31, 2016 Assets Current Assets Accounts receivable, net of allowance for doubtful accounts $ 146 Inventories, net 33 All other current assets 21 Total current assets of discontinued operations 200 Noncurrent Assets Property, plant and equipment 739 Mineral leaseholds, net 730 Other long-term assets 2 Total assets of discontinued operations $ 1,671 Liabilities Current Liabilities Accounts payable $ 44 Accrued liabilities 36 All other current liabilities 11 Total current liabilities of discontinued operations 91 All other long-term liabilities 20 Total liabilities of discontinued operations $ 111

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Taxes [Abstract]
Income Taxes	3. Income Taxes Our operations are conducted through our various subsidiaries in a number of countries throughout the world. We have provided for income taxes based upon the tax laws and rates in the countries in which operations are conducted and income is earned. Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Income tax provision $ (13 ) $ (6 ) $ (10 ) $ (25 ) Income (loss) from continuing operations before income taxes $ (12 ) $ (56 ) $ (85 ) $ (213 ) Effective tax rate (108 )% (11 )% (12 )% (12 )% During the fourth quarter of 2016, we implemented various steps of an internal corporate restructuring plan to simplify our corporate, finance and legal structure and thereby improve operational, administrative, and commercial synergies (the “Corporate Reorganization”). As a result of this Corporate Reorganization, we reduced our cross jurisdictional financing arrangements during 2016; therefore, the three and nine months period ended September 30, 2017 is not impacted by withholding tax accruals on interest income. In connection with the Corporate Reorganization during the three months period ended March 31, 2017, Tronox Limited became managed and controlled in the United Kingdom (“U.K”), with no additional impacts to the consolidated provision for income taxes due to the valuation allowances in various jurisdictions. During the nine months ended September 30, 2017, Tronox Limited, the public parent which is registered under the laws of the State of Western Australia, became managed and controlled in the U.K. The statutory tax rate in the U.K. at September 30, 2017 was 19%. During 2016, Tronox Limited was managed and controlled in Australia which has a statutory tax rate of 30%. During the three months ended September 30, 2017 we sold the Alkali segment of our operations. The Alkali results are now shown as discontinued operations and are not included in the tabular results above. The effective tax rate for the three months ended September 30, 2017 differs from both the three months ended September 30, 2016, and the nine months ended September 30, 2017 primarily due to the discrete results of reporting the effects of this sale. Additionally, the effective tax rate for the three and nine months ended September 30, 2017 differs from the U.K. statutory rate of 19% primarily due to valuation allowances, income in foreign jurisdictions taxed at rates different than 19%. The effective tax rate for the three and nine months ended September 30, 2016 differs from the Australian statutory rate of 30% primarily due to valuation allowances and income in foreign jurisdictions taxed at rates lower than 30%, and withholding tax accruals on interest income. The income tax provision for the three and nine months ended September 30, 2017 differs from the income tax provision for the three and nine months ended September 30, 2016 due to withholding tax accruals on interest income which we made during 2016. The statutory tax rates in various countries where subsidiaries of Tronox Limited have operations are different than both the U.K. and the Australian tax rates. Tax rates in the United States (“U.S.”) (35% for corporations), South Africa (28% for limited liability companies), the Netherlands (25% for corporations), Switzerland (8.5% for corporations) and Jersey, U.K. (0% for corporations) all impact our effective tax rate. We continue to maintain full valuation allowances related to the total net deferred tax assets in Australia, the Netherlands, and the U.S., as we cannot objectively assert that these deferred tax assets are more likely than not to be realized. Future provisions for income taxes will include no tax benefits with respect to losses incurred and tax expense only to the extent of current state tax payments until the valuation allowances are eliminated. Additionally, we have valuation allowances against specific tax assets in South Africa, and during the nine month period ended September 30, 2017 we established a valuation allowance of $7 million against deferred tax assets in the U.K. which we do not currently expect to utilize. These conclusions were reached by the application of ASC 740, Income Taxes The Company is currently under audit in Australia and the United States. We believe that we have made adequate provision for income taxes that may be payable with respect to years open for examination; however, the ultimate outcome is not presently known and, accordingly, additional provisions may be necessary and/or reclassifications of noncurrent tax liabilities to current may occur in the future.

Income (Loss) Per Share

Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2017
Income (Loss) Per Share [Abstract]
Income (Loss) Per Share	4. Income (Loss) Per Share The computation of basic and diluted income (loss) per share for the periods indicated is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Numerator – Basic and Diluted: Net income (loss) from continuing operations $ (25 ) $ (62 ) $ (95 ) $ (238 ) Less: Net income (loss) from continuing operations attributable to noncontrolling interest 6 (2 ) 11 (1 ) Undistributed net income (loss) from continuing operations attributable to Tronox Limited (31 ) (60 ) (106 ) (237 ) Percentage allocated to ordinary shares (1) 100 % 100 % 100 % 100 % Net income (loss) from continuing operations available to ordinary shares (31 ) (60 ) (106 ) (237 ) Net income (loss) from discontinued operations available to ordinary shares (216 ) 23 (179 ) 55 Net income (loss) available to ordinary shares $ (247 ) $ (37 ) $ (285 ) $ (182 ) Denominator – Basic and Diluted: Weighted-average ordinary shares, basic and diluted (in thousands) 119,405 116,219 118,908 116,108 Net income (loss) per Ordinary Share (2) Basic and diluted net income (loss) from continuing operations per ordinary share $ (0.26 ) $ (0.53 ) $ (0.89 ) $ (2.04 ) Basic and diluted net income (loss) from discontinued operations per ordinary share (1.81 ) 0.20 (1.51 ) 0.47 Basic and diluted net income (loss) per ordinary share $ (2.07 ) $ (0.33 ) $ (2.40 ) $ (1.57 ) (1) Our participating securities do not have a contractual obligation to share in losses; therefore, when we have a net loss, none of the loss is allocated to participating securities. Consequently, for the three and nine months ended September 30, 2017 and 2016, the two-class method did not have an effect on our net loss per ordinary share calculation, and as such, dividends paid during the year did not impact this calculation. (2) Loss per ordinary share amounts were calculated from exact, not rounded, loss and share information. In computing diluted net income (loss) per share under the two-class method, we considered potentially dilutive shares. Anti-dilutive shares not recognized in the diluted net loss per share calculation for the nine months ended September 30, 2017 and 2016 were as follows: September 30, 2017 September 30, 2016 Shares Average Exercise Price Shares Average Exercise Price Options 1,827,354 $ 21.21 1,997,437 $ 21.20 Series A Warrants (1) 960,371 $ 8.51 1,440,652 $ 8.51 Series B Warrants (1) 1,009,283 $ 9.37 1,953,250 $ 9.37 Restricted share units 5,548,071 $ 11.22 5,566,589 $ 7.18 (1) Series A Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.02. Series B Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.03.

Accounts Receivable, Net of All

Accounts Receivable, Net of Allowance for Doubtful Accounts	9 Months Ended
	Sep. 30, 2017
Accounts Receivable, Net of Allowance for Doubtful Accounts [Abstract]
Accounts Receivable, Net of Allowance for Doubtful Accounts	5. Accounts Receivable, Net of Allowance for Doubtful Accounts Accounts receivable, net of allowance for doubtful accounts, consisted of the following: September 30, 2017 December 31, 2016 Trade receivables $ 298 $ 271 Other 12 8 Subtotal 310 279 Allowance for doubtful accounts (1 ) (1 ) Accounts receivable, net of allowance for doubtful accounts $ 309 $ 278

Inventories, Net

Inventories, Net	9 Months Ended
	Sep. 30, 2017
Inventories, Net [Abstract]
Inventories, Net	6. Inventories, Net Inventories, net consisted of the following: September 30, 2017 December 31, 2016 Raw materials $ 161 $ 191 Work-in-process 30 35 Finished goods, net 184 190 Materials and supplies, net (1) 98 97 Total 473 513 Less: Inventories, net – non-current (14 ) (14 ) Inventories, net - current $ 459 $ 499 (1) Consists of processing chemicals, maintenance supplies, and spare parts, which will be consumed directly and indirectly in the production of our products. Finished goods include inventory on consignment of $29 million and $24 million at September 30, 2017 and December 31, 2016, respectively. At September 30, 2017 and December 31, 2016, inventory obsolescence reserves primarily for materials and supplies were $15 and $17 million, respectively. At September 30, 2017 and December 31, 2016, reserves for lower of cost or market were $17 million and $26 million, respectively.

Property, Plant and Equipment,

Property, Plant and Equipment, Net	9 Months Ended
	Sep. 30, 2017
Property, Plant and Equipment, Net [Abstract]
Property, Plant and Equipment, Net	7. Property, Plant and Equipment, Net Property, plant and equipment, net of accumulated depreciation, consisted of the following: September 30, 2017 December 31, 2016 Land and land improvements $ 94 $ 94 Buildings 244 237 Machinery and equipment 1,316 1,275 Construction-in-progress 103 82 Other 40 38 Subtotal 1,797 1,726 Less accumulated depreciation and amortization (728 ) (634 ) Property, plant and equipment, net (1) $ 1,069 $ 1,092 (1) Substantially all of these assets are pledged as collateral for our debt. See Note 11. Depreciation expense related to property, plant and equipment during the three months ended September 30, 2017 and 2016 was $31 million and $30 million, respectively, of which $30 million and $29 million, respectively, was recorded in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations and $1 million each was recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. Depreciation expense related to property, plant and equipment during the nine months ended September 30, 2017 and 2016 was $93 million and $86 million, respectively, of which $91 million and $84 million, respectively, was recorded in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations and $2 million each was recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations.

Mineral Leaseholds, Net

Mineral Leaseholds, Net	9 Months Ended
	Sep. 30, 2017
Mineral Leaseholds, Net [Abstract]
Mineral Leaseholds, Net	8. Mineral Leaseholds, Net Mineral leaseholds, net of accumulated depletion, consisted of the following: September 30, 2017 December 31, 2016 Mineral leaseholds $ 1,263 $ 1,257 Less: accumulated depletion (404 ) (380 ) Mineral leaseholds, net $ 859 $ 877 Depletion expense relating to mineral leaseholds recorded in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations was $8 million during each of the three months ended September 30, 2017 and 2016 and $24 million and $26 million, respectively, during the nine months ended September 30, 2017 and 2016.

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Sep. 30, 2017
Intangible Assets, Net [Abstract]
Intangible Assets, Net	9. Intangible Assets, Net Intangible assets, net of accumulated amortization, consisted of the following: September 30, 2017 December 31, 2016 Gross Cost Accumulated Amortization Net Carrying Amount Gross Cost Accumulated Amortization Net Carrying Amount Customer relationships $ 291 $ (129 ) $ 162 $ 291 $ (115 ) $ 176 TiO 2 32 (11 ) 21 32 (9 ) 23 Internal-use software 44 (24 ) 20 45 (21 ) 24 Intangible assets, net $ 367 $ (164 ) $ 203 $ 368 $ (145 ) $ 223 Amortization expense related to intangible assets during each of the three months ended September 30, 2017 and 2016 was $6 million of which less than $1 million each was recorded in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations and $6 million each was recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. Amortization expense related to intangible assets during each of the nine months ended September 30, 2017 and 2016 was $19 million of which $1 million each was recorded in “Cost of goods sold” in the unaudited Condensed Consolidated Statements of Operations and $18 million each was recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. Estimated future amortization expense related to intangible assets is $6 million for the remainder of 2017, $25 million each for 2018 through 2021, and $97 million thereafter.

Accrued Liabilities

Accrued Liabilities	9 Months Ended
	Sep. 30, 2017
Accrued Liabilities [Abstract]
Accrued Liabilities	10. Accrued Liabilities Accrued liabilities consisted of the following: September 30, 2017 December 31, 2016 Employee-related costs and benefits $ 63 $ 61 Interest 5 35 Sales rebates 19 20 Taxes other than income taxes 11 9 Professional fees and other 33 25 Accrued liabilities $ 131 $ 150

Debt

Debt	9 Months Ended
	Sep. 30, 2017
Debt [Abstract]
Debt	11. Debt Debt Refinancing On September 22, 2017, we completed our offering of our Senior Notes due 2025 for an aggregate principal amount of $450 million, the net proceeds of which, together with borrowings under our $2.150 billion New Term Loan Facility and proceeds from the Alkali sale, funded the redemption of the remaining outstanding balance of our Senior Notes due 2020 and repayment in full of the remaining outstanding balance of our $1.5 billion Prior Term Loan. In addition, we paid off our UBS Revolver and entered into a new asset-based revolving syndicated facility with Wells Fargo (all defined below). The refinancing of our Senior Notes due 2020 was considered a debt extinguishment in accordance with ASC 470, Debt (“ASC 470”). However, for refinancing of both the UBS Revolver and the New Term Loan Facility, a portion of each of these refinancing arrangements were considered modifications and a portion considered extinguishments in accordance with the requirements of ASC 470 as some of the original lenders in the original syndications were part of the new lender base. Short-term Debt During the third quarter of 2017, we repaid the $150 million outstanding balance under the global senior secured asset-based syndicated revolving credit facility with UBS AG (the “UBS Revolver”). Concurrent with entering into the Wells Fargo Revolver, described below, the UBS Revolver was terminated. Unamortized original debt issuance costs of $1 million relating to the UBS Revolver were included in “Gain (loss) on extinguishment of debt” in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2017. The remaining unamortized balance of original debt issuance costs of $2 million relating to the UBS Revolver will be amortized over the life of the Wells Fargo Revolver. Wells Fargo Revolver On September 22, 2017, we entered into a new global senior secured asset-based syndicated revolving credit facility with the lenders party thereto and Wells Fargo Bank, N.A. as administrative agent (the “Wells Fargo Revolver”). The Wells Fargo Revolver provides us with up to $550 million of revolving credit loans, with an $85 million sublimit for letters of credit, and has a maturity date of September 22, 2022. Our availability of revolving credit loans and letters of credit is subject to a borrowing base. Borrowings bear interest at our option, at either an adjusted London Interbank Offered Rate (“LIBOR”) plus an applicable margin that ranges from 1.25% to 1.75%, or a base rate, which is defined to mean the greatest of (a) the administrative agent’s prime rate, (b) the Federal funds effective rate plus 0.50% and (c) the adjusted LIBOR for a one-month period plus 1.00%, plus an applicable margin that ranges from 0.25% to 0.75%, in each case, based on the average daily borrowing availability. At September 30, 2017, there was no outstanding revolving credit loans under the Wells Fargo Revolver, except for $19 million of issued and undrawn letters of credit under the Wells Fargo Revolver. Debt issuance costs associated with the Wells Fargo Revolver of $6 million ($2 million remaining from the UBS Revolver and $4 million incurred for the Wells Fargo Revolver) were Long-term debt, net of an unamortized discount and debt issuance costs, consisted of the following: Original Principal Annual Interest Rate Maturity Date September 30, 2017 December 31, 2016 Prior Term Loan, net of unamortized discount (1) $ 1,500 Variable 3/20/2020 $ — $ 1,441 New Term Loan Facility, net of unamortized discount (2) $ 2,150 Variable 9/22/2024 $ 2,136 $ — Senior Notes due 2020 900 6.375 % 8/15/2020 — 896 Senior Notes due 2022 600 7.50 % 3/15/2022 584 584 Senior Notes due 2025 450 5.75 % 9/22/2025 450 — Lease financing 17 19 Long-term debt 3,187 2,940 Less: Long-term debt due within one year (11 ) (16 ) Debt issuance costs (47 ) (36 ) Long-term debt, net $ 3,129 $ 2,888 (1) Average effective interest rate of 5.2% and 5.1% during the three and nine months ended September 30, 2017, respectively, and 4.9% each during the three and nine months ended September 30, 2016. (2) Average effective interest rate of 4.5% during each of the three and nine months ended September 30, 2017. At September 30, 2017, the scheduled maturities of our long-term debt were as follows: Total Borrowings 2017 $ — 2018 17 2019 22 2020 22 2021 22 Thereafter 3,118 Total 3,201 Remaining accretion associated with the New Term Loans (14 ) Total borrowings $ 3,187 Prior Term Loan On April 23, 2014, we, along with our wholly owned subsidiary, Tronox Pigments (Netherlands) B.V., and certain named guarantor subsidiaries, entered into a Third Amended and Restated Credit and Guaranty Agreement (the “Third Agreement”) with the lenders party thereto and Goldman Sachs Bank USA, as administrative agent. Pursuant to the Third Agreement, we obtained a $1.5 billion senior secured term loan (the “Prior Term Loan”) with a maturity date of March 19, 2020. As mentioned above, on September 22, 2017, we repaid the remaining $1.4 billion outstanding balance of the $1.5 billion Prior Term Loan and entered into the New Term Loan Facility described below. Unamortized original debt discount and issuance costs of $1 million relating to the Prior Term Loan were included in “Gain (loss) on extinguishment of debt” in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2017. The remaining balance of unamortized original debt discount and issuance costs of $16 million relating to the Prior Term Loan will continue to be amortized over the life of the New Term Loan Facility. New Term Loan Facility On September 22, 2017, we entered into a new senior secured first lien term loan facility (the “New Term Loan Facility”) with the lenders party thereto and Bank of America, N.A., as administrative agent, with a maturity date of September 22, 2024. The New Term Loan Facility consists of (i) a U.S. dollar term facility in an aggregate principal amount of $1.5 billion (the “New Term Loans”) with our subsidiary, Tronox Finance LLC (“Tronox Finance”) as the borrower and (ii) a U.S. dollar term facility in an aggregate principal amount of $650 million (the “Blocked Term Loan”) with our unrestricted subsidiary, Tronox Blocked Borrower LLC (the “Blocked Borrower”) as the borrower, which Blocked Term Loan was funded into a blocked account. Upon consummation of the Cristal acquisition, the Blocked Borrower will merge with and into Tronox Finance, and the Blocked Term Loan will become available to Tronox Finance. If the Cristal Acquisition is terminated, the Blocked Term Loan will be repaid to the lenders of such Blocked Term Loan. The proceeds from the Blocked Term Loan were included in “Restricted cash” in the Condensed Consolidated Balance Sheets at September 30, 2017. The term loans under the New Term Loan Facility bear interest at the “Applicable Rate” defined by reference to a grid pricing matrix that relates to our first lien net leverage ratio. Based upon our first lien net leverage ratio, the Applicable Rate under the New Term Loan Facility as of September 30, 2017 was 300 basis points plus LIBOR. The New Term Loan Facility was issued net of an original issue discount of $11 million. Debt issuance costs of $4 million relating to the New Term Loans were included in “Gain (loss) on extinguishment of debt” in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2017. Debt issuance costs of $30 million associated with the New Term Loan Facility ($13 million remaining from the Prior Term Loan and $17 million incurred for the New Term Loan Facility) were recorded as a direct reduction of the carrying value of the long-term debt as described below and will be amortized over the life of the New Term Loan Facility. Senior Notes due 2020 On September 25, 2017, we redeemed (the “Redemption”) the $896 million outstanding balance of our $900 million aggregate principal, 6.375% senior notes due 2020 issued by Tronox Finance (the “Senior Notes due 2020”). The total cash payment made in connection with the Redemption was approximately $917 million, and included accrued interest of $7 million and a call premium of $14 million (the “Call Premium”) included in “Gain (loss) on extinguishment of debt” in the unaudited Condensed Consolidated Statements of Operations. During the nine months ended September 30, 2016, we repurchased $4 million of face value of the Senior Notes due 2020 at a price of 77% of par, resulting in a net gain of approximately $1 million which was included in “Gain (loss) on extinguishment of debt” in the unaudited Condensed Consolidated Statements of Operations. The Senior Notes due 2020 were fully and unconditionally guaranteed on a senior and unsecured basis by us and certain of our subsidiaries. As a result of the Redemption, we are no longer required to present guarantor condensed consolidating financial statements starting with this Form 10-Q for the period ended September 30, 2017. In connection with the Redemption, we recorded a loss on extinguishment of debt of $22 million included in “Gain (loss) on extinguishment of debt”, of which $8 million related to unamortized debt issuance costs and $14 million related to the Call Premium. Senior Notes due 2022 We have $600 million aggregate principal amount, 7.50% Senior Notes due 2022 (the “Senior Notes due 2022”) which notes were issued pursuant to an indenture dated March 19, 2015 (the “2022 Indenture”). The Senior Notes due 2022 have not been registered under the Securities Act, and may not be offered or sold in the U.S. absent registration or an applicable exemption from registration requirements. There were no repayments during the three and nine months ended September 30, 2017. During the nine months ended September 30, 2016, we repurchased $16 million of face value of notes at a weighted average price of 76% of par, resulting in a net gain of approximately $3 million which was included in “Gain (loss) on extinguishment of debt” in the unaudited Condensed Consolidated Statements of Operations. The Indenture and the Senior Notes due 2022 provide, among other things, that the Senior Notes due 2022 are senior unsecured obligations of Tronox Finance and are guaranteed on a senior and unsecured basis by us and certain of our other subsidiaries. Interest is payable on March 15 and September 15 of each year until their maturity date of March 15, 2022. The terms of the 2022 Indenture, among other things, limit, in certain circumstances, the ability of us to: incur certain additional indebtedness and issue preferred stock; make certain dividends, distributions, investments and other restricted payments; sell certain assets; incur liens; agree to any restrictions on the ability of certain subsidiaries to make payments to us; consolidate or merge with or into, or sell substantially all of our assets to, another person; enter into transactions with affiliates; and enter into new lines of business. At September 30, 2017 and December 31, 2016, debt issuance costs related to the Senior Notes due 2022 of $8 million and $10 million, respectively, were recorded as a direct reduction of the carrying value of the long-term debt as described below. Senior Notes due 2025 On September 22, 2017, our wholly-owned subsidiary Tronox Finance plc, issued 5.75% senior notes due 2025 for an aggregate principal amount of $450 million (the “Senior Notes due 2025”), which notes were issued under an indenture dated September 22, 2017 (the “2025 Indenture”). The 2025 Indenture and the Senior Notes due 2025 provide, among other things, that the Senior Notes due 2025 are senior unsecured obligations of Tronox Finance plc and are guaranteed on a senior and unsecured basis by us and certain of our other subsidiaries. The Senior Notes due 2025 have not been registered under the Securities Act, and may not be offered or sold in the U.S. absent registration or an applicable exemption from registration requirements. Interest is payable on April 1 and October 1 of each year beginning on April 1, 2018 until their maturity date of October 1, 2025. The terms of the 2025 Indenture, among other things, limit, in certain circumstances, the ability of us and certain of our subsidiaries to: incur secured indebtedness, engage in certain sale-leaseback transactions and merge, consolidate or sell substantially all of our assets. The terms of the 2025 Indenture also include certain limitations on our non-guarantor subsidiaries incurring indebtedness. Debt issuance costs of $9 million relating to the Senior Notes due 2025 were recorded as a direct reduction of the carrying value of the long-term debt as described below Liquidity and Capital Resources As of September 30, 2017, we had $238 million available under the $550 million Wells Fargo Revolver and $1.1 billion in cash and cash equivalents. In addition, restricted cash as of September 30, 2017 included the $650 million proceeds from the Blocked Term Loan discussed above. Lease Financing We have capital lease obligations in South Africa, which are payable through 2031 at a weighted average interest rate of approximately 14%. At September 30, 2017 and December 31, 2016, assets recorded under capital lease obligations were $21 million and $7 million, respectively. Related accumulated amortization was $7 million and $6 million at September 30, 2017 and December 31, 2016, respectively. During each of the three and nine months ended September 30, 2017 and 2016, we made principal payments of less than $1 million. Fair Value Our debt is recorded at historical amounts. At September 30, 2017 and December 31, 2016, the fair value of the New Term Loan Facility was $2.2 billion. At September 30, 2017 and December 31, 2016, the fair value of the Senior Notes due 2022 was $616 million and $544 million, respectively. At September 30, 2017 the fair value of our Senior Notes due 2025 was $461 million. We determined the fair value of the New Term Loan Facility, the Senior Notes due 2022 and the Senior Notes due 2025 using quoted market prices. The fair value hierarchy for the New Term Loan Facility, the Senior Notes due 2022 and the Senior Notes due 2025 is a Level 1 input. Balances outstanding under our Wells Fargo Revolver are carried at contracted amounts, which approximate fair value based on the short term nature of the borrowing and the variable interest rate. The fair value hierarchy for our Wells Fargo Revolver is a Level 2 input. Debt Covenants At September 30, 2017, we had no financial covenants in the Wells Fargo Revolver and the New Term Loan Facility. We were in compliance with all our reporting covenants as of and for the three and nine months ended September 30, 2017. Interest and Debt Expense, Net Interest and debt expense, net in the unaudited Condensed Consolidated Statements of Operations consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Interest on Prior Term Loan $ 16 $ 17 $ 49 $ 50 Interest on New Term Loan Facility 2 — 2 — Interest on Senior Notes due 2020 13 14 41 43 Interest on Senior Notes due 2022 11 11 33 33 Interest on Senior Notes due 2025 1 — 1 — Amortization of deferred debt issuance costs and discounts on debt 3 3 9 8 Other 2 1 7 6 Capitalized interest (1 ) — (2 ) (2 ) Total interest and debt expense, net $ 47 $ 46 $ 140 $ 138 In connection with obtaining debt, we incurred debt issuance costs, which are being amortized through the respective maturity dates using the effective interest method. At September 30, 2017, we had deferred debt issuance costs of $6 million related to the Wells Fargo Revolver which is recorded in “Other long-term assets” in the unaudited Condensed Consolidated Balance Sheets. At September 30, 2017, we had $30 million and $9 million of debt discount and issuance costs related to the New Term Loan Facility and the Senior Notes due 2025, respectively, which was recorded as a direct reduction of the carrying value of the long term debt in the unaudited Condensed Consolidated Balance Sheets. At September 30, 2017 and December 31, 2016, we had $8 million and $10 million, respectively, of debt issuance costs related to the Senior Notes 2022, which were recorded as a direct reduction of the carrying value of the long term debt in the unaudited Condensed Consolidated Balance Sheets.

Asset Retirement Obligations

Asset Retirement Obligations	9 Months Ended
	Sep. 30, 2017
Asset Retirement Obligations [Abstract]
Asset Retirement Obligations	12. Asset Retirement Obligations Asset retirement obligations consist primarily of rehabilitation and restoration costs, landfill capping costs, decommissioning costs, and closure and post-closure costs. Activity related to asset retirement obligations was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Beginning balance $ 80 $ 78 $ 76 $ 81 Additions 1 — 1 1 Accretion expense 2 1 4 4 Remeasurement/translation — 3 4 5 Changes in estimates, including cost and timing of cash flows — — — (9 ) Settlements/payments (1 ) — (3 ) — Balance, September 30, $ 82 $ 82 $ 82 $ 82 Asset retirement obligations in our unaudited Condensed Consolidated Balance Sheets at September 30, 2017 and December 31, 2016 consist of a current portion of $4 million and $3 million, respectively, included in “Accrued liabilities” and a noncurrent portion of $78 million and $73 million, respectively, included in “Asset retirement obligations”. During the nine months ended September 30, 2016, we amended our lease agreement for our TiO 2

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies [Abstract]
Commitments and Contingencies	13. Commitments and Contingencies Purchase and Capital Commitments Letters of Credit — Other Matters

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2017
Shareholders' Equity [Abstract]
Shareholders' Equity	14. Shareholders’ Equity The changes in outstanding Class A Shares and Class B Shares for the nine months ended September 30, 2017 were as follows: Class A Shares: Balance at January 1, 2017 65,165,672 Shares issued for share-based compensation 3,034,771 Shares issued upon warrants exercised 964,897 Shares issued upon options exercised 45,753 Shares issued cancelled for share-based compensation (619,999 ) Balance at September 30, 2017 68,591,094 Class B Shares: Balance, at both September 30, 2017 and December 31, 2016 51,154,280 Warrants We have outstanding Series A Warrants (the “Series A Warrants”) and Series B Warrants (the “Series B Warrants”), together (the “Warrants”). At September 30, 2017, holders of the Series A Warrants and the Series B Warrants were entitled to purchase 6.02 and 6.03 of Class A Shares, respectively, and receive $12.50 in cash at an exercise price of $51.21 for each Series A Warrant and $56.51 for each Series B Warrant. The Warrants have a seven-year term from the date initially issued and will expire on February 14, 2018. A holder may exercise the Warrants by paying the applicable exercise price in cash or exercising on a cashless basis. The Warrants are freely transferable by the holder. At September 30, 2017 and December 31, 2016, there were 159,530 and 239,306 Series A Warrants outstanding, respectively, and 167,377 and 323,915 Series B Warrants outstanding, respectively. Dividends During 2017, we declared and paid quarterly dividends to holders of our Class A Shares and Class B Shares as follows: Three Months Ended March 31, 2017 Three Months Ended June 30, 2017 Three Months Ended September 30, 2017 Dividend per share $ 0.045 $ 0.045 $ 0.045 Total dividend $ 6 $ 6 $ 5 Record date (close of business) March 6 May 15 August 21 During 2016, we declared and paid quarterly dividends to holders of our Class A Shares and Class B Shares as follows: Three Months Ended March 31, 2016 Three Months Ended June 30, 2016 Three Months Ended September 30, 2016 Dividend per share $ 0.25 $ 0.045 $ 0.045 Total dividend $ 30 $ 5 $ 5 Record date (close of business) March 4 May 16 August 17 Accumulated Other Comprehensive Loss Attributable to Tronox Limited The tables below present changes in accumulated other comprehensive income (loss) by component for the three months ended September 30, 2017 and 2016. Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (363 ) $ (91 ) $ — $ (454 ) Other comprehensive income (loss) (26 ) — — (26 ) Amounts reclassified from accumulated other comprehensive income (loss) — 6 — 6 Balance, September 30, 2017 $ (389 ) (85 ) — (474 ) Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (456 ) $ (101 ) $ 2 $ (555 ) Other comprehensive income (loss) 51 (21 ) (1 ) 29 Amounts reclassified from accumulated other comprehensive income (loss) — (1 ) — (1 ) Balance, September 30, 2016 $ (405 ) $ (123 ) $ 1 $ (527 ) The tables below present changes in accumulated other comprehensive income (loss) by component for the nine months ended September 30, 2017 and 2016. Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (408 ) $ (92 ) $ 3 $ (497 ) Other comprehensive income (loss) 19 — (3 ) 16 Amounts reclassified from accumulated other comprehensive income (loss) — 7 — 7 Balance, September 30, 2017 $ (389 ) (85 ) — (474 ) Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (496 ) $ (102 ) $ — $ (598 ) Other comprehensive income (loss) 91 (21 ) 1 71 Balance, September 30, 2016 $ (405 ) $ (123 ) $ 1 $ (527 )

Noncontrolling Interest

Noncontrolling Interest	9 Months Ended
	Sep. 30, 2017
Noncontrolling Interest [Abstract]
Noncontrolling Interest	15. Noncontrolling Interest At September 30, 2017, Exxaro has a 26% ownership interest in each of our Tronox KZN Sands (Pty) Ltd. and Tronox Mineral Sands (Pty) Ltd. subsidiaries in order to comply with the ownership requirements of the Black Economic Empowerment legislation in South Africa. Exxaro is entitled to exchange this interest for approximately 3.2% in additional Class B Shares under certain circumstances. Exxaro also has a 26% ownership interest in certain of our other non-operating subsidiaries. We account for such ownership interest as “Noncontrolling interest” in the unaudited condensed consolidated financial statements. Noncontrolling interest activity for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Beginning balance $ 162 $ 126 $ 144 $ 112 Net income (loss) attributable to noncontrolling interest 6 (2 ) 11 (1 ) Effect of exchange rate changes (10 ) 18 3 31 Balance, September 30, $ 158 $ 142 $ 158 $ 142

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Sep. 30, 2017
Share-Based Compensation [Abstract]
Share-Based Compensation	16. Share-Based Compensation Share-based compensation expense consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Restricted shares and restricted share units $ 5 $ 7 $ 25 $ 15 Options — 1 — 2 T-Bucks Employee Participation Plan — — 1 1 Total share-based compensation expense $ 5 $ 8 $ 26 $ 18 Tronox Limited Management Equity Incentive Plan Restricted Shares We did not grant any restricted shares during the nine months ended September 30, 2017. The following table presents a summary of activity for the nine months ended September 30, 2017: Number of Shares Weighted Average Grant Date Fair Value Outstanding, January 1, 2017 284,400 $ 6.09 Vested (107,928 ) 8.00 Outstanding, September 30, 2017 176,472 $ 4.92 Expected to vest, September 30, 2017 176,472 $ 4.92 At September 30, 2017, there was less than $l million of unrecognized compensation expense related to unvested restricted shares which is expected to be recognized over a weighted-average period of 1.1 years. Since the restricted shares were granted only to certain members of our Board, the unrecognized compensation expense was not adjusted for estimated forfeitures. The total fair value of restricted shares that vested during the nine months ended September 30, 2017 was $1 million. Restricted Share Units (“RSUs”) During the nine months ended September 30, 2017, we granted RSUs which have time and/or performance conditions. Both the time-based awards and the performance-based awards are classified as equity awards. For the time-based awards, 1,075 RSUs vested immediately, 14,053 RSUs vest ratably over a nine-month period 100,160 RSUs vest ratably over a one-year period and 12,869 RSUs vest ratably over a three-year period, and are valued at the weighted average grant date fair value. For the performance-based awards, 1,145,933 cliff vest at the end of the three years and 12,865 cliff vest at the end of forty months. Included in the performance-based awards are 786,639 RSUs for which vesting is determined based on a relative Total Stockholder Return (“TSR”) calculation over the applicable measurement period. The TSR metric is considered a market condition for which we use a Monte Carlo simulation to determine the grant date fair value. A total of 1,225,697 RSUs were granted, pursuant to an Integration Incentive Award program (the “Integration Incentive Award”) established in connection with the Cristal Transaction, to certain executive officers and managers with significant integration accountability. If the Cristal Transaction does not close by July 1, 2018, then the Integration Incentive Award granted will be cancelled. The following table presents a summary of activity for the nine months ended September 30, 2017 Number of Shares Weighted Average Grant Date Fair Value Outstanding, January 1, 2017 5,587,331 $ 7.19 Granted 2,944,267 17.19 Vested (2,378,609 ) 9.52 Forfeited (604,918 ) 9.81 Outstanding, September 30, 2017 5,548,071 $ 11.22 Expected to vest, September 30, 2017 5,797,277 $ 9.83 At September 30, 2017, there was $35 million of unrecognized compensation expense related to unvested RSUs, adjusted for estimated forfeitures, which is expected to be recognized over a weighted-average period of 2.0 years. The weighted-average grant-date fair value of RSUs granted during the nine months ended September 30, 2017 and 2016 was $17.19 per share and $4.04 per share, respectively. The total fair value of RSUs that vested during the nine months ended September 30, 2017 was $23 million. Options The following table presents a summary of activity for the nine months ended September 30, 2017: Number of Options Weighted Average Exercise Price Weighted Average Contractual Life (years) Intrinsic Value Outstanding, January 1, 2017 1,970,481 $ 21.19 6.38 $ — Exercised (45,753 ) 19.32 Forfeited (4,273 ) 21.98 Expired (93,101 ) 21.58 Outstanding, September 30, 2017 1,827,354 $ 21.21 4.62 $ 2 Expected to vest, September 30, 2017 789 $ 22.69 1.27 $ — Exercisable, September 30, 2017 1,826,560 $ 21.21 4.61 $ 2 The aggregate intrinsic values in the table represent the total pre-tax intrinsic value (the difference between our share price at the indicated dates and the options’ exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at the end of the period. The amount will change based on the fair market value of our stock. The total intrinsic value of options exercised during the three and nine months ended September 30, 2017 was less than $1 million. No options were exercised during the three and nine months ending September 30, 2016 and consequently, there was no related intrinsic value. We issue new shares upon the exercise of options. During the three and nine months ended September 30, 2017, we received approximately $1 million in cash for the stock options exercised. As there were no stock options exercised during the three and nine months ended September 30, 2016, no cash was received. At September 30, 2017, we had no unrecognized compensation expense related to options, adjusted for estimated forfeitures. We did not issue any options during the nine months ended September 30, 2017. T-Bucks Employee Participation Plan (“T-Bucks EPP”) During 2012, we established the T-Bucks EPP for the benefit of certain qualifying employees of our South African subsidiaries. We funded a T-Bucks Trust (the “Trust”) with R124 million (approximately $15 million), which was used to acquire Class A Shares. On May 31, 2017, the shares held by the Trust became fully vested. The Trust sold 546,403 shares in June 2017 on behalf of the participants who elected to receive cash. The remaining participants elected to receive shares. Long-Term Incentive Plan (“LTIP”) We have a LTIP for the benefit of certain qualifying employees of Tronox subsidiaries in South Africa and Australia. The LTIP is classified as a cash-settled compensation plan and is re-measured to fair value at each reporting date. We did not have an outstanding liability for LTIP at both September 30, 2017 and December 31, 2016.

Pension and Other Postretiremen

Pension and Other Postretirement Healthcare Benefits	9 Months Ended
	Sep. 30, 2017
Pension and Other Postretirement Healthcare Benefits [Abstract]
Pension and Other Postretirement Healthcare Benefits	17. Pension and Other Postretirement Healthcare Benefits We sponsor a noncontributory defined benefit retirement plan in the U. S., the qualified retirement plan (the “U.S. Qualified Retirement Plan”). We also have a collective defined contribution plan (a multiemployer plan) in the Netherlands, and a postretirement healthcare plan in South Africa. We had a defined benefit retirement plan in the Netherlands which was settled in the fourth quarter of 2016. We sponsored a noncontributory defined benefit plan that covered eligible employees of Alkali which became effective from the acquisition date of Alkali, on April 1, 2015 (the “Alkali Qualified Plan”). Our obligations under the Alkali Qualified Plan transferred with the Sale and $5 million in actuarial losses and prior service costs previously included in “Accumulated other comprehensive loss” were recognized as a loss within “Income (loss) from discontinued operations, net of tax” on the Statement of Operations in the third quarter of 2017. The components of net periodic cost associated with our U.S. Qualified Retirement Plan and The Netherlands defined benefit plan recognized in the unaudited Condensed Consolidated Statements of Operations were as follows Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net periodic cost: Service cost $ — $ — $ — $ — Interest cost 3 5 11 15 Expected return on plan assets (4 ) (5 ) (11 ) (15 ) Net amortization of actuarial loss and prior service credit 1 — 2 1 Curtailment gain (loss) — (1 ) — (1 ) Total net periodic cost $ — $ (1 ) $ 2 $ — The components of net periodic cost associated with the postretirement healthcare plans was less than $1 million each for the three and nine months ended September 30, 2017 and 2016. The components of net periodic cost associated with the postretirement healthcare plan was $1 million for each of the nine months ended September 30, 2017 and 2016. For each of the three and nine month periods ended September 30, 2017 and 2016, we contributed $1 million and $3 million, respectively, to The Netherlands multiemployer plan, which was primarily recognized in “Cost of goods sold” in the unaudited Condensed Consolidated Statement of Operations.

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2017
Related Parties [Abstract]
Related Parties	18. Related Parties Exxaro We have service level agreements with Exxaro for research and development that expired during the third quarter of 2017. Such service level agreements amounted to less than $1 million of expense during each of the three months and nine months ended September 30, 2017 and 2016, which was included in “Selling, general and administrative expense” in the unaudited Condensed Consolidated Statements of Operations. Additionally, we had a professional service agreement with Exxaro related to the Fairbreeze construction project which ended in January 2017. Payments were nil and $1 million, respectively, to Exxaro relating to Fairbreeze during the three months ended September 30, 2017 and 2016 and less than $1 million and $2 million, respectively, during the nine months ended September 30, 2017 and 2016. These payments were capitalized and included in “Property, plant and equipment, net” in our unaudited Condensed Consolidated Balance Sheets. At both September 30, 2017 and December 31, 2016, we had less than $1 million of related party payables, which were recorded in “Accounts payable” in our unaudited Condensed Consolidated Balance Sheets.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2017
Segment Information [Abstract]
Segment Information	19. Segment Information Segment performance is evaluated based on segment operating income (loss), which represents the results of segment operations before unallocated costs, such as general corporate expenses not identified to a specific segment, interest expense, other income (expense), net and income tax expense or benefit. Net sales and income (loss) from operations by segment were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net sales (TiO 2 $ 435 $ 339 $ 1,234 $ 957 TiO 2 $ 75 $ 17 $ 168 $ (12 ) Corporate (24 ) (17 ) (90 ) (45 ) Income (loss) from operations 51 — 78 (57 ) Interest and debt expense, net (47 ) (46 ) (140 ) (138 ) Gain on extinguishment of debt (28 ) — (28 ) 4 Other income (expense), net 12 (10 ) 5 (22 ) Income (loss) from continuing operations before income taxes $ (12 ) $ (56 ) $ (85 ) $ (213 )

The Company (Policies)

The Company (Policies)	9 Months Ended
	Sep. 30, 2017
The Company [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements are unaudited, and have been prepared pursuant to the rules and regulations of the U. S. Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016. The Condensed Consolidated Balance Sheet as of December 31, 2016 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, considered necessary for a fair statement. Our unaudited condensed consolidated financial statements include the accounts of all majority-owned subsidiary companies. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the manner and presentation in the current period. As a result of the Alkali disposition, the results of Alkali have been reclassified as discontinued operations for all periods presented. See Note 2 – Discontinued Operations for additional information. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that the effect on the financial statements of a change in estimate due to one or more future confirming events could have a material effect on the financial statements.
Revision of Previously Issued Consolidated Financial Statements	Revision of Previously Issued Consolidated Financial Statements During the three months ended March 31, 2017, we identified a misstatement in our selling, general, and administrative expense for certain prior periods related to a liability resulting from a non-timely filing with a statutory authority. The aggregate misstatement is $11 million, which impacts our previously issued consolidated statements of operations, comprehensive loss, balance sheets and cash flows as of and for the years ended December 31, 2015 and 2016, and the unaudited condensed consolidated financial statements for the third and fourth quarters and corresponding year-to-date periods of 2015, and each quarter and corresponding year-to-date periods of 2016. In accordance with Staff Accounting Bulletin (“SAB”) No. 99, Materiality Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements The effects on our unaudited condensed consolidated financial statements are as follows: Unaudited Condensed Consolidated Statement of Operations Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported (1) Adjustment Revised As Reported (1) Adjustment Revised Net sales $ 339 $ — $ 339 $ 957 $ — $ 957 Cost of goods sold 290 1 291 877 — 877 Gross profit 49 (1 ) 48 80 — 80 Selling, general and administrative expenses (47 ) — (47 ) (131 ) (4 ) (135 ) Income (loss) from operations 1 (1 ) — (53 ) (4 ) (57 ) Other income (expense), net (13 ) 3 (10 ) (22 ) — (22 ) Income (loss) from continuing operations before income taxes (58 ) 2 (56 ) (209 ) (4 ) (213 ) Net income (loss) from continuing operations (64 ) 2 (62 ) (235 ) (3 ) (238 ) Income (loss) from discontinued operations, net of tax 22 1 23 53 2 55 Net loss attributable to Tronox Limited (40 ) 3 (37 ) (181 ) (1 ) (182 ) Net income (loss) per share from continuing operations, basic and diluted (0.54 ) 0.01 (0.53 ) (2.02 ) (0.02 ) (2.04 ) Net income (loss) per share from discontinued operations, basic and diluted 0.19 0.01 0.20 0.46 0.01 0.47 Weighted average shares outstanding, basic and diluted (in thousands) 116,219 116,219 116,219 116,108 116,108 116,108 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported Adjustment Revised As Reported Adjustment Revised Net loss $ (42 ) $ 3 $ (39 ) $ (182 ) $ (1 ) $ (183 ) Total comprehensive income ( loss) 4 3 7 (80 ) (1 ) (81 ) Comprehensive loss attributable to Tronox Limited (12 ) 3 (9 ) (110 ) (1 ) (111 ) Unaudited Condensed Consolidated Balance Sheet December 31, 2016 As Reported (1) Adjustment Revised Current assets of continuing operations $ 1,067 $ — $ 1,067 Total assets of discontinued operations 1,668 3 1,671 Total current assets 2,735 3 2,738 Total assets 4,961 3 4,964 Accrued liabilities 138 11 149 Current liabilities of continuing operations 443 10 453 Total liabilities of discontinued operations 110 1 111 Total current liabilities 553 11 564 Total liabilities 3,800 11 3,811 Accumulated deficit (13 ) (6 ) (19 ) Accumulated other comprehensive loss (495 ) (2 ) (497 ) Total Tronox Limited shareholders’ equity 1,017 (8 ) 1,009 Total equity 1,161 (8 ) 1,153 Total liabilities and equity 4,961 3 4,964 (1) Amounts reflect the results of Alkali as discontinued operations. Unaudited Condensed Consolidated Statement of Cash Flows There was no net impact to operating, investing and financing cash flows from the revisions for continuing operations for the nine months ended September 30, 2016.
Adopted Accounting Pronouncements	Adopted Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Improvements to Employee Share-Based Payment Accounting Compensation – Stock Compensation In March 2016, the FASB issued ASU 2016-05, Derivatives and Hedging: Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships Derivatives and Hedging In July 2015, as part of its simplification initiative, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements We consider the applicability and impact of all recently issued ASUs. Those not listed below were assessed and determined to be either not applicable or expected to have a minimal impact on our consolidated financial statements. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities In May 2017, the FASB issued ASU 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting In March 2017, the FASB issued ASU 2017-07, Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230) In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In February 2016, the FASB issued ASU 2016-02, Leases In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606)

The Company (Tables)

The Company (Tables)	9 Months Ended
	Sep. 30, 2017
The Company [Abstract]
Revision of Previously Issued Consolidated Financial Statements	The effects on our unaudited condensed consolidated financial statements are as follows: Unaudited Condensed Consolidated Statement of Operations Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported (1) Adjustment Revised As Reported (1) Adjustment Revised Net sales $ 339 $ — $ 339 $ 957 $ — $ 957 Cost of goods sold 290 1 291 877 — 877 Gross profit 49 (1 ) 48 80 — 80 Selling, general and administrative expenses (47 ) — (47 ) (131 ) (4 ) (135 ) Income (loss) from operations 1 (1 ) — (53 ) (4 ) (57 ) Other income (expense), net (13 ) 3 (10 ) (22 ) — (22 ) Income (loss) from continuing operations before income taxes (58 ) 2 (56 ) (209 ) (4 ) (213 ) Net income (loss) from continuing operations (64 ) 2 (62 ) (235 ) (3 ) (238 ) Income (loss) from discontinued operations, net of tax 22 1 23 53 2 55 Net loss attributable to Tronox Limited (40 ) 3 (37 ) (181 ) (1 ) (182 ) Net income (loss) per share from continuing operations, basic and diluted (0.54 ) 0.01 (0.53 ) (2.02 ) (0.02 ) (2.04 ) Net income (loss) per share from discontinued operations, basic and diluted 0.19 0.01 0.20 0.46 0.01 0.47 Weighted average shares outstanding, basic and diluted (in thousands) 116,219 116,219 116,219 116,108 116,108 116,108 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016 As Reported Adjustment Revised As Reported Adjustment Revised Net loss $ (42 ) $ 3 $ (39 ) $ (182 ) $ (1 ) $ (183 ) Total comprehensive income ( loss) 4 3 7 (80 ) (1 ) (81 ) Comprehensive loss attributable to Tronox Limited (12 ) 3 (9 ) (110 ) (1 ) (111 ) Unaudited Condensed Consolidated Balance Sheet December 31, 2016 As Reported (1) Adjustment Revised Current assets of continuing operations $ 1,067 $ — $ 1,067 Total assets of discontinued operations 1,668 3 1,671 Total current assets 2,735 3 2,738 Total assets 4,961 3 4,964 Accrued liabilities 138 11 149 Current liabilities of continuing operations 443 10 453 Total liabilities of discontinued operations 110 1 111 Total current liabilities 553 11 564 Total liabilities 3,800 11 3,811 Accumulated deficit (13 ) (6 ) (19 ) Accumulated other comprehensive loss (495 ) (2 ) (497 ) Total Tronox Limited shareholders’ equity 1,017 (8 ) 1,009 Total equity 1,161 (8 ) 1,153 Total liabilities and equity 4,961 3 4,964 (1) Amounts reflect the results of Alkali as discontinued operations.

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2017
Discontinued Operations [Abstract]
Financial Information of Discontinued Operations	The following table presents the major classes of Alkali’s line items constituting the “Income (loss) from discontinued operations, net of tax” in our Condensed Consolidated Statements of Operations: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net sales $ 129 $ 194 $ 521 $ 590 Cost of goods sold 113 163 448 511 Selling, general and administrative expenses (6 ) (7 ) (18 ) (20 ) Income before income taxes 10 24 55 59 Income tax benefit (provision) 7 (1 ) (1 ) (4 ) Loss on sale of discontinued operations, no tax impact (233 ) — (233 ) — Income (loss) from discontinued operations $ (216 ) $ 23 $ (179 ) $ 55 The following table is a summary of the carrying amounts of Alkali’s assets and liabilities included as “Total assets of discontinued operations” and “Total liabilities of discontinued operations” of December 31, 2016: December 31, 2016 Assets Current Assets Accounts receivable, net of allowance for doubtful accounts $ 146 Inventories, net 33 All other current assets 21 Total current assets of discontinued operations 200 Noncurrent Assets Property, plant and equipment 739 Mineral leaseholds, net 730 Other long-term assets 2 Total assets of discontinued operations $ 1,671 Liabilities Current Liabilities Accounts payable $ 44 Accrued liabilities 36 All other current liabilities 11 Total current liabilities of discontinued operations 91 All other long-term liabilities 20 Total liabilities of discontinued operations $ 111

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2017
Income Taxes [Abstract]
Summary of Income Taxes	Our operations are conducted through our various subsidiaries in a number of countries throughout the world. We have provided for income taxes based upon the tax laws and rates in the countries in which operations are conducted and income is earned. Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Income tax provision $ (13 ) $ (6 ) $ (10 ) $ (25 ) Income (loss) from continuing operations before income taxes $ (12 ) $ (56 ) $ (85 ) $ (213 ) Effective tax rate (108 )% (11 )% (12 )% (12 )%

Income (Loss) Per Share (Tables

Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2017
Income (Loss) Per Share [Abstract]
Computation of Basic and Diluted Income (Loss) per Share	The computation of basic and diluted income (loss) per share for the periods indicated is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Numerator – Basic and Diluted: Net income (loss) from continuing operations $ (25 ) $ (62 ) $ (95 ) $ (238 ) Less: Net income (loss) from continuing operations attributable to noncontrolling interest 6 (2 ) 11 (1 ) Undistributed net income (loss) from continuing operations attributable to Tronox Limited (31 ) (60 ) (106 ) (237 ) Percentage allocated to ordinary shares (1) 100 % 100 % 100 % 100 % Net income (loss) from continuing operations available to ordinary shares (31 ) (60 ) (106 ) (237 ) Net income (loss) from discontinued operations available to ordinary shares (216 ) 23 (179 ) 55 Net income (loss) available to ordinary shares $ (247 ) $ (37 ) $ (285 ) $ (182 ) Denominator – Basic and Diluted: Weighted-average ordinary shares, basic and diluted (in thousands) 119,405 116,219 118,908 116,108 Net income (loss) per Ordinary Share (2) Basic and diluted net income (loss) from continuing operations per ordinary share $ (0.26 ) $ (0.53 ) $ (0.89 ) $ (2.04 ) Basic and diluted net income (loss) from discontinued operations per ordinary share (1.81 ) 0.20 (1.51 ) 0.47 Basic and diluted net income (loss) per ordinary share $ (2.07 ) $ (0.33 ) $ (2.40 ) $ (1.57 ) (1) Our participating securities do not have a contractual obligation to share in losses; therefore, when we have a net loss, none of the loss is allocated to participating securities. Consequently, for the three and nine months ended September 30, 2017 and 2016, the two-class method did not have an effect on our net loss per ordinary share calculation, and as such, dividends paid during the year did not impact this calculation. (2) Loss per ordinary share amounts were calculated from exact, not rounded, loss and share information.
Anti-Dilutive Shares Not Recognized in Diluted Earnings per Share Calculation	Anti-dilutive shares not recognized in the diluted net loss per share calculation for the nine months ended September 30, 2017 and 2016 were as follows: September 30, 2017 September 30, 2016 Shares Average Exercise Price Shares Average Exercise Price Options 1,827,354 $ 21.21 1,997,437 $ 21.20 Series A Warrants (1) 960,371 $ 8.51 1,440,652 $ 8.51 Series B Warrants (1) 1,009,283 $ 9.37 1,953,250 $ 9.37 Restricted share units 5,548,071 $ 11.22 5,566,589 $ 7.18 (1) Series A Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.02. Series B Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.03.

Accounts Receivable, Net of A33

Accounts Receivable, Net of Allowance for Doubtful Accounts (Tables)	9 Months Ended
	Sep. 30, 2017
Accounts Receivable, Net of Allowance for Doubtful Accounts [Abstract]
Components of Accounts Receivable, Net of Allowance for Doubtful Accounts	Accounts receivable, net of allowance for doubtful accounts, consisted of the following: September 30, 2017 December 31, 2016 Trade receivables $ 298 $ 271 Other 12 8 Subtotal 310 279 Allowance for doubtful accounts (1 ) (1 ) Accounts receivable, net of allowance for doubtful accounts $ 309 $ 278

Inventories, Net (Tables)

Inventories, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Inventories, Net [Abstract]
Components of Inventories, Net	Inventories, net consisted of the following: September 30, 2017 December 31, 2016 Raw materials $ 161 $ 191 Work-in-process 30 35 Finished goods, net 184 190 Materials and supplies, net (1) 98 97 Total 473 513 Less: Inventories, net – non-current (14 ) (14 ) Inventories, net - current $ 459 $ 499 (1) Consists of processing chemicals, maintenance supplies, and spare parts, which will be consumed directly and indirectly in the production of our products.

Property, Plant and Equipment35

Property, Plant and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Property, Plant and Equipment, Net [Abstract]
Components of Property, Plant and Equipment, Net of Accumulated Depreciation	Property, plant and equipment, net of accumulated depreciation, consisted of the following: September 30, 2017 December 31, 2016 Land and land improvements $ 94 $ 94 Buildings 244 237 Machinery and equipment 1,316 1,275 Construction-in-progress 103 82 Other 40 38 Subtotal 1,797 1,726 Less accumulated depreciation and amortization (728 ) (634 ) Property, plant and equipment, net (1) $ 1,069 $ 1,092 (1) Substantially all of these assets are pledged as collateral for our debt. See Note 11.

Mineral Leaseholds, Net (Tables

Mineral Leaseholds, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Mineral Leaseholds, Net [Abstract]
Summary of Mineral Leaseholds, Net of Accumulated Depletion	Mineral leaseholds, net of accumulated depletion, consisted of the following: September 30, 2017 December 31, 2016 Mineral leaseholds $ 1,263 $ 1,257 Less: accumulated depletion (404 ) (380 ) Mineral leaseholds, net $ 859 $ 877

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Intangible Assets, Net [Abstract]
Components of Intangible Assets, Net of Accumulated Amortization	Intangible assets, net of accumulated amortization, consisted of the following: September 30, 2017 December 31, 2016 Gross Cost Accumulated Amortization Net Carrying Amount Gross Cost Accumulated Amortization Net Carrying Amount Customer relationships $ 291 $ (129 ) $ 162 $ 291 $ (115 ) $ 176 TiO 2 32 (11 ) 21 32 (9 ) 23 Internal-use software 44 (24 ) 20 45 (21 ) 24 Intangible assets, net $ 367 $ (164 ) $ 203 $ 368 $ (145 ) $ 223

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2017
Accrued Liabilities [Abstract]
Components of Accrued Liabilities	Accrued liabilities consisted of the following: September 30, 2017 December 31, 2016 Employee-related costs and benefits $ 63 $ 61 Interest 5 35 Sales rebates 19 20 Taxes other than income taxes 11 9 Professional fees and other 33 25 Accrued liabilities $ 131 $ 150

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt [Abstract]
Components of Long-Term Debt, Net of Unamortized Discount and Debt Issuance Costs	Long-term debt, net of an unamortized discount and debt issuance costs, consisted of the following: Original Principal Annual Interest Rate Maturity Date September 30, 2017 December 31, 2016 Prior Term Loan, net of unamortized discount (1) $ 1,500 Variable 3/20/2020 $ — $ 1,441 New Term Loan Facility, net of unamortized discount (2) $ 2,150 Variable 9/22/2024 $ 2,136 $ — Senior Notes due 2020 900 6.375 % 8/15/2020 — 896 Senior Notes due 2022 600 7.50 % 3/15/2022 584 584 Senior Notes due 2025 450 5.75 % 9/22/2025 450 — Lease financing 17 19 Long-term debt 3,187 2,940 Less: Long-term debt due within one year (11 ) (16 ) Debt issuance costs (47 ) (36 ) Long-term debt, net $ 3,129 $ 2,888 (1) Average effective interest rate of 5.2% and 5.1% during the three and nine months ended September 30, 2017, respectively, and 4.9% each during the three and nine months ended September 30, 2016. (2) Average effective interest rate of 4.5% during each of the three and nine months ended September 30, 2017.
Scheduled Maturities of Long-term Debt	At September 30, 2017, the scheduled maturities of our long-term debt were as follows: Total Borrowings 2017 $ — 2018 17 2019 22 2020 22 2021 22 Thereafter 3,118 Total 3,201 Remaining accretion associated with the New Term Loans (14 ) Total borrowings $ 3,187
Summary of Interest and Debt Expense, Net	Interest and debt expense, net in the unaudited Condensed Consolidated Statements of Operations consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Interest on Prior Term Loan $ 16 $ 17 $ 49 $ 50 Interest on New Term Loan Facility 2 — 2 — Interest on Senior Notes due 2020 13 14 41 43 Interest on Senior Notes due 2022 11 11 33 33 Interest on Senior Notes due 2025 1 — 1 — Amortization of deferred debt issuance costs and discounts on debt 3 3 9 8 Other 2 1 7 6 Capitalized interest (1 ) — (2 ) (2 ) Total interest and debt expense, net $ 47 $ 46 $ 140 $ 138

Asset Retirement Obligations (T

Asset Retirement Obligations (Tables)	9 Months Ended
	Sep. 30, 2017
Asset Retirement Obligations [Abstract]
Activity Related to Asset Retirement Obligations	Asset retirement obligations consist primarily of rehabilitation and restoration costs, landfill capping costs, decommissioning costs, and closure and post-closure costs. Activity related to asset retirement obligations was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Beginning balance $ 80 $ 78 $ 76 $ 81 Additions 1 — 1 1 Accretion expense 2 1 4 4 Remeasurement/translation — 3 4 5 Changes in estimates, including cost and timing of cash flows — — — (9 ) Settlements/payments (1 ) — (3 ) — Balance, September 30, $ 82 $ 82 $ 82 $ 82

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2017
Shareholders' Equity [Abstract]
Changes in Outstanding Shares	The changes in outstanding Class A Shares and Class B Shares for the nine months ended September 30, 2017 were as follows: Class A Shares: Balance at January 1, 2017 65,165,672 Shares issued for share-based compensation 3,034,771 Shares issued upon warrants exercised 964,897 Shares issued upon options exercised 45,753 Shares issued cancelled for share-based compensation (619,999 ) Balance at September 30, 2017 68,591,094 Class B Shares: Balance, at both September 30, 2017 and December 31, 2016 51,154,280
Schedule of Dividends Declared and Paid	During 2017, we declared and paid quarterly dividends to holders of our Class A Shares and Class B Shares as follows: Three Months Ended March 31, 2017 Three Months Ended June 30, 2017 Three Months Ended September 30, 2017 Dividend per share $ 0.045 $ 0.045 $ 0.045 Total dividend $ 6 $ 6 $ 5 Record date (close of business) March 6 May 15 August 21 During 2016, we declared and paid quarterly dividends to holders of our Class A Shares and Class B Shares as follows: Three Months Ended March 31, 2016 Three Months Ended June 30, 2016 Three Months Ended September 30, 2016 Dividend per share $ 0.25 $ 0.045 $ 0.045 Total dividend $ 30 $ 5 $ 5 Record date (close of business) March 4 May 16 August 17
Changes in Accumulated Other Comprehensive Income (Loss) by Component	The tables below present changes in accumulated other comprehensive income (loss) by component for the three months ended September 30, 2017 and 2016. Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (363 ) $ (91 ) $ — $ (454 ) Other comprehensive income (loss) (26 ) — — (26 ) Amounts reclassified from accumulated other comprehensive income (loss) — 6 — 6 Balance, September 30, 2017 $ (389 ) (85 ) — (474 ) Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (456 ) $ (101 ) $ 2 $ (555 ) Other comprehensive income (loss) 51 (21 ) (1 ) 29 Amounts reclassified from accumulated other comprehensive income (loss) — (1 ) — (1 ) Balance, September 30, 2016 $ (405 ) $ (123 ) $ 1 $ (527 ) The tables below present changes in accumulated other comprehensive income (loss) by component for the nine months ended September 30, 2017 and 2016. Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (408 ) $ (92 ) $ 3 $ (497 ) Other comprehensive income (loss) 19 — (3 ) 16 Amounts reclassified from accumulated other comprehensive income (loss) — 7 — 7 Balance, September 30, 2017 $ (389 ) (85 ) — (474 ) Cumulative Translation Adjustment Pension Liability Adjustment Unrealized Gains (Losses) on Derivatives Total Beginning balance $ (496 ) $ (102 ) $ — $ (598 ) Other comprehensive income (loss) 91 (21 ) 1 71 Balance, September 30, 2016 $ (405 ) $ (123 ) $ 1 $ (527 )

Noncontrolling Interest (Tables

Noncontrolling Interest (Tables)	9 Months Ended
	Sep. 30, 2017
Noncontrolling Interest [Abstract]
Summary of Noncontrolling Interest Activity	Noncontrolling interest activity for the three and nine months ended September 30, 2017 and 2016 was as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Beginning balance $ 162 $ 126 $ 144 $ 112 Net income (loss) attributable to noncontrolling interest 6 (2 ) 11 (1 ) Effect of exchange rate changes (10 ) 18 3 31 Balance, September 30, $ 158 $ 142 $ 158 $ 142

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2017
Share-Based Compensation [Abstract]
Components of Share-based Compensation Expense	Share-based compensation expense consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Restricted shares and restricted share units $ 5 $ 7 $ 25 $ 15 Options — 1 — 2 T-Bucks Employee Participation Plan — — 1 1 Total share-based compensation expense $ 5 $ 8 $ 26 $ 18
Summary of Activity for Restricted Shares	The following table presents a summary of activity for the nine months ended September 30, 2017: Number of Shares Weighted Average Grant Date Fair Value Outstanding, January 1, 2017 284,400 $ 6.09 Vested (107,928 ) 8.00 Outstanding, September 30, 2017 176,472 $ 4.92 Expected to vest, September 30, 2017 176,472 $ 4.92
Summary of Activity for Restricted Share Units (RSUs)	The following table presents a summary of activity for the nine months ended September 30, 2017 Number of Shares Weighted Average Grant Date Fair Value Outstanding, January 1, 2017 5,587,331 $ 7.19 Granted 2,944,267 17.19 Vested (2,378,609 ) 9.52 Forfeited (604,918 ) 9.81 Outstanding, September 30, 2017 5,548,071 $ 11.22 Expected to vest, September 30, 2017 5,797,277 $ 9.83
Summary of Activity for Options	The following table presents a summary of activity for the nine months ended September 30, 2017: Number of Options Weighted Average Exercise Price Weighted Average Contractual Life (years) Intrinsic Value Outstanding, January 1, 2017 1,970,481 $ 21.19 6.38 $ — Exercised (45,753 ) 19.32 Forfeited (4,273 ) 21.98 Expired (93,101 ) 21.58 Outstanding, September 30, 2017 1,827,354 $ 21.21 4.62 $ 2 Expected to vest, September 30, 2017 789 $ 22.69 1.27 $ — Exercisable, September 30, 2017 1,826,560 $ 21.21 4.61 $ 2

Pension and Other Postretirem44

Pension and Other Postretirement Healthcare Benefits (Tables)	9 Months Ended
	Sep. 30, 2017
Pension and Other Postretirement Healthcare Benefits [Abstract]
Components of Net Periodic Cost Associated with the U.S. Defined Benefit Plans and The Netherlands Defined Plan	The components of net periodic cost associated with our U.S. Qualified Retirement Plan and The Netherlands defined benefit plan recognized in the unaudited Condensed Consolidated Statements of Operations were as follows Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net periodic cost: Service cost $ — $ — $ — $ — Interest cost 3 5 11 15 Expected return on plan assets (4 ) (5 ) (11 ) (15 ) Net amortization of actuarial loss and prior service credit 1 — 2 1 Curtailment gain (loss) — (1 ) — (1 ) Total net periodic cost $ — $ (1 ) $ 2 $ —

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2017
Segment Information [Abstract]
Net Sales and Income (Loss) from Operations by Segment	Net sales and income (loss) from operations by segment were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Net sales (TiO 2 $ 435 $ 339 $ 1,234 $ 957 TiO 2 $ 75 $ 17 $ 168 $ (12 ) Corporate (24 ) (17 ) (90 ) (45 ) Income (loss) from operations 51 — 78 (57 ) Interest and debt expense, net (47 ) (46 ) (140 ) (138 ) Gain on extinguishment of debt (28 ) — (28 ) 4 Other income (expense), net 12 (10 ) 5 (22 ) Income (loss) from continuing operations before income taxes $ (12 ) $ (56 ) $ (85 ) $ (213 )

The Company (Details)

The Company (Details) $ / shares in Units, $ in Millions	Oct. 10, 2017shares	Sep. 01, 2017USD ($)	Feb. 21, 2017USD ($)$ / sharesshares	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)Segment	Sep. 30, 2016USD ($)	Dec. 31, 2016Segment	Dec. 31, 2012
Schedule of Equity Method Investments [Line Items]
Number of reporting segments | Segment						1		2
Proceeds from sale of business						$ 1,325	$ 0
Exxaro [Member]
Schedule of Equity Method Investments [Line Items]
Acquisition percentage									74.00%
Percentage of Tronox Limited's voting securities				43.00%		43.00%		44.00%
Exxaro [Member] | Subsequent Event [Member]
Schedule of Equity Method Investments [Line Items]
Acquisition percentage	24.00%
Exxaro [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Ownership interest				50.00%		50.00%
Tronox KZN Sands (Pty) Ltd. [Member]
Schedule of Equity Method Investments [Line Items]
Ownership interest				26.00%		26.00%
Tronox Mineral Sands (Pty) Ltd. [Member]
Schedule of Equity Method Investments [Line Items]
Ownership interest				26.00%		26.00%
Class A [Member] | Exxaro [Member] | Subsequent Event [Member]
Schedule of Equity Method Investments [Line Items]
Number of ordinary shares to be issued for acquisition (in shares) | shares	22,425,000
Alkali Chemicals Group [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds from sale of business		$ 1,325
Pre-tax loss on disposal of discontinued operation				$ (233)	$ 0	$ (233)	$ 0
Transaction fees related to sale of disposal group				$ 21
Cristal's Titanium Dioxide Business [Member]
Schedule of Equity Method Investments [Line Items]
Cash consideration for acquisition			$ 1,673
Acquisition percentage			24.00%
Contract termination fee						$ 100
Cristal's Titanium Dioxide Business [Member] | Class A [Member]
Schedule of Equity Method Investments [Line Items]
Number of ordinary shares to be issued for acquisition (in shares) | shares			37,580,000
Ordinary shares, par value (in dollars per share) | $ / shares			$ 0.01

The Company, Revision of Previo

The Company, Revision of Previously Issued Consolidated Financial Statements (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Increase (decrease) in cost of goods sold	$ 329		$ 291	$ 971	$ 877
Non-timely Filing [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Aggregate misstatement which impacts prior year financial statements		$ 11
Overstated Depreciation Expense [Member] | Out of Period Correction in 2014 One [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Increase (decrease) in cost of goods sold		(6)
Overstated Depreciation Expense [Member] | Out of Period Correction in 2014 Two [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Increase (decrease) in cost of goods sold		(5)
Royalty Tax [Member] | Out of Period Correction in 2014 One [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Increase (decrease) in cost of goods sold		$ 7

The Company, Impact of Misstate

The Company, Impact of Misstatements on Financial Statements (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Unaudited Condensed Consolidated Statement of Operations [Abstract]
Net sales		$ 435	$ 339	$ 1,234	$ 957
Cost of goods sold		329	291	971	877
Gross profit		106	48	263	80
Selling, general and administrative expenses		(55)	(47)	(186)	(135)
Income (loss) from operations		51	0	78	(57)
Other income (expense), net		12	(10)	5	(22)
Income (loss) from continuing operations before income taxes		(12)	(56)	(85)	(213)
Net income (loss) from continuing operations		(25)	(62)	(95)	(238)
Income (loss) from discontinued operations, net of tax		(216)	23	(179)	55
Net loss attributable to Tronox Limited		$ (247)	$ (37)	$ (285)	$ (182)
Net income (loss) per share from continuing operations, basic and diluted (in dollars per share)	[1]	$ (0.26)	$ (0.53)	$ (0.89)	$ (2.04)
Net income (loss) per share from discontinued operations, basic and diluted (in dollars per share)	[1]	$ (1.81)	$ 0.20	$ (1.51)	$ 0.47
Weighted average shares outstanding, basic and diluted (in shares)		119,405	116,219	118,908	116,108
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net loss		$ (241)	$ (39)	$ (274)	$ (183)
Total comprehensive income ( loss)		(271)	7	(248)	(81)
Comprehensive loss attributable to Tronox Limited		(267)	(9)	(262)	(111)
Unaudited Condensed Consolidated Balance Sheet [Abstract]
Current assets of continuing operations						$ 1,067
Total assets of discontinued operations		0		0		1,671
Total current assets		2,524		2,524		2,738
Total assets		4,691		4,691		4,964
Accrued liabilities		131		131		150
Current liabilities of continuing operations						453
Total liabilities of discontinued operations		0		0		111
Total current liabilities		299		299		564
Total liabilities		3,785		3,785		3,811
Accumulated deficit		(321)		(321)		(19)
Accumulated other comprehensive loss		(474)		(474)		(497)
Total Tronox Limited shareholders' equity		748		748		1,009
Total equity		906		906		1,153
Total liabilities and equity		$ 4,691		$ 4,691		4,964
As Reported [Member]
Unaudited Condensed Consolidated Statement of Operations [Abstract]
Net sales	[2]		339		957
Cost of goods sold	[2]		290		877
Gross profit	[2]		49		80
Selling, general and administrative expenses	[2]		(47)		(131)
Income (loss) from operations	[2]		1		(53)
Other income (expense), net	[2]		(13)		(22)
Income (loss) from continuing operations before income taxes	[2]		(58)		(209)
Net income (loss) from continuing operations	[2]		(64)		(235)
Income (loss) from discontinued operations, net of tax	[2]		22		53
Net loss attributable to Tronox Limited	[2]		$ (40)		$ (181)
Net income (loss) per share from continuing operations, basic and diluted (in dollars per share)	[2]		$ (0.54)		$ (2.02)
Net income (loss) per share from discontinued operations, basic and diluted (in dollars per share)	[2]		$ 0.19		$ 0.46
Weighted average shares outstanding, basic and diluted (in shares)	[2]		116,219		116,108
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net loss			$ (42)		$ (182)
Total comprehensive income ( loss)			4		(80)
Comprehensive loss attributable to Tronox Limited			(12)		(110)
Unaudited Condensed Consolidated Balance Sheet [Abstract]
Current assets of continuing operations	[2]					1,067
Total assets of discontinued operations	[2]					1,668
Total current assets	[2]					2,735
Total assets	[2]					4,961
Accrued liabilities	[2]					138
Current liabilities of continuing operations	[2]					443
Total liabilities of discontinued operations	[2]					110
Total current liabilities	[2]					553
Total liabilities	[2]					3,800
Accumulated deficit	[2]					(13)
Accumulated other comprehensive loss	[2]					(495)
Total Tronox Limited shareholders' equity	[2]					1,017
Total equity	[2]					1,161
Total liabilities and equity	[2]					4,961
Adjustment [Member]
Unaudited Condensed Consolidated Statement of Operations [Abstract]
Net sales			0		0
Cost of goods sold			1		0
Gross profit			(1)		0
Selling, general and administrative expenses			0		(4)
Income (loss) from operations			(1)		(4)
Other income (expense), net			3		0
Income (loss) from continuing operations before income taxes			2		(4)
Net income (loss) from continuing operations			2		(3)
Income (loss) from discontinued operations, net of tax			1		2
Net loss attributable to Tronox Limited			$ 3		$ (1)
Net income (loss) per share from continuing operations, basic and diluted (in dollars per share)			$ 0.01		$ (0.02)
Net income (loss) per share from discontinued operations, basic and diluted (in dollars per share)			$ 0.01		$ 0.01
Weighted average shares outstanding, basic and diluted (in shares)			116,219		116,108
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net loss			$ 3		$ (1)
Total comprehensive income ( loss)			3		(1)
Comprehensive loss attributable to Tronox Limited			$ 3		$ (1)
Unaudited Condensed Consolidated Balance Sheet [Abstract]
Current assets of continuing operations						0
Total assets of discontinued operations						3
Total current assets						3
Total assets						3
Accrued liabilities						11
Current liabilities of continuing operations						10
Total liabilities of discontinued operations						1
Total current liabilities						11
Total liabilities						11
Accumulated deficit						(6)
Accumulated other comprehensive loss						(2)
Total Tronox Limited shareholders' equity						(8)
Total equity						(8)
Total liabilities and equity						3
As Revised Prior to Reclassification [Member]
Unaudited Condensed Consolidated Balance Sheet [Abstract]
Accrued liabilities						$ 149
[1]	Loss per ordinary share amounts were calculated from exact, not rounded, loss and share information.
[2]	Amounts reflect the results of Alkali as discontinued operations.

Discontinued Operations (Detail

Discontinued Operations (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)Segment	Sep. 30, 2016USD ($)	Dec. 31, 2016USD ($)Segment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of operating segments | Segment			1		2
Number of reporting segments | Segment			1		2
Condensed Consolidated Statements of Operations [Abstract]
Income (loss) from discontinued operations	$ (216)	$ 23	$ (179)	$ 55
Current Assets [Abstract]
Total current assets of discontinued operations	0		0		$ 1,671
Current Liabilities [Abstract]
Total current liabilities of discontinued operations	0		0		111
Alkali Chemicals Group [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Allocated corporate costs	1	3	1	3
Condensed Consolidated Statements of Operations [Abstract]
Net sales	129	194	521	590
Cost of goods sold	113	163	448	511
Selling, general and administrative expenses	(6)	(7)	(18)	(20)
Income before income taxes	10	24	55	59
Income tax benefit (provision)	7	(1)	(1)	(4)
Loss on sale of discontinued operations, no tax impact	(233)	0	(233)	0
Income (loss) from discontinued operations	$ (216)	$ 23	$ (179)	$ 55
Current Assets [Abstract]
Accounts receivable, net of allowance for doubtful accounts					146
Inventories, net					33
All other current assets					21
Total current assets of discontinued operations					200
Noncurrent Assets [Abstract]
Property, plant and equipment					739
Mineral leaseholds, net					730
Other long-term assets					2
Total assets of discontinued operations					1,671
Current Liabilities [Abstract]
Accounts payable					44
Accrued liabilities					36
All other current liabilities					11
Total current liabilities of discontinued operations					91
All other long-term liabilities					20
Total liabilities of discontinued operations					$ 111

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Taxes [Abstract]
Income tax provision	$ (13)	$ (6)	$ (10)	$ (25)
Income (loss) from continuing operations before income taxes	$ (12)	$ (56)	$ (85)	$ (213)
Effective tax rate	(108.00%)	(11.00%)	(12.00%)	(12.00%)
United Kingdom [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate	19.00%		19.00%
Deferred tax assets, valuation allowances	$ 7		$ 7
Australia [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate		30.00%		30.00%
South Africa [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate			28.00%
Netherlands [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate			25.00%
U.S. Federal [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate			35.00%
Switzerland [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate			8.50%
Jersey, U.K. [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Statutory tax rate			0.00%

Income (Loss) Per Share, Comput

Income (Loss) Per Share, Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Numerator - Basic and Diluted [Abstract]
Net income (loss) from continuing operations		$ (25)	$ (62)	$ (95)	$ (238)
Less: Net income (loss) from continuing operations attributable to noncontrolling interest		6	(2)	11	(1)
Undistributed net income (loss) from continuing operations attributable to Tronox Limited		$ (31)	$ (60)	$ (106)	$ (237)
Percentage allocated to ordinary shares	[1]	100.00%	100.00%	100.00%	100.00%
Net income (loss) from continuing operations available to ordinary shares		$ (31)	$ (60)	$ (106)	$ (237)
Net income (loss) from discontinued operations available to ordinary shares		(216)	23	(179)	55
Net income (loss) available to ordinary shares		$ (247)	$ (37)	$ (285)	$ (182)
Denominator - Basic and Diluted [Abstract]
Weighted-average ordinary shares, basic and diluted (in shares)		119,405	116,219	118,908	116,108
Net income (loss) per Ordinary Share [Abstract]
Basic and diluted net income (loss) from continuing operations per ordinary share (in dollars per share)	[2]	$ (0.26)	$ (0.53)	$ (0.89)	$ (2.04)
Basic and diluted net income (loss) from discontinued operations per ordinary share (in dollars per share)	[2]	(1.81)	0.20	(1.51)	0.47
Net income (loss) per share, basic and diluted (in dollars per share)	[2]	$ (2.07)	$ (0.33)	$ (2.40)	$ (1.57)
[1]	Our participating securities do not have a contractual obligation to share in losses; therefore, when we have a net loss, none of the loss is allocated to participating securities. Consequently, for the three and nine months ended September 30, 2017 and 2016, the two-class method did not have an effect on our net loss per ordinary share calculation, and as such, dividends paid during the year did not impact this calculation.
[2]	Loss per ordinary share amounts were calculated from exact, not rounded, loss and share information.

Income (Loss) Per Share, Comp52

Income (Loss) Per Share, Computation of Anti-Dilutive Shares (Details) - $ / shares		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares (in shares)		1,827,354	1,997,437
Average exercise price (in dollars per share)		$ 21.21	$ 21.20
Series A Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares (in shares)	[1]	960,371	1,440,652
Average exercise price (in dollars per share)	[1]	$ 8.51	$ 8.51
Warrant conversion rate (in shares)		6.02	6.02
Series B Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares (in shares)	[1]	1,009,283	1,953,250
Average exercise price (in dollars per share)	[1]	$ 9.37	$ 9.37
Warrant conversion rate (in shares)		6.03	6.03
Restricted Share Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares (in shares)		5,548,071	5,566,589
Average exercise price (in dollars per share)		$ 11.22	$ 7.18
[1]	Series A Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.02. Series B Warrants were converted into Class A ordinary shares at September 30, 2017 and 2016 using a rate of 6.03.

Accounts Receivable, Net of A53

Accounts Receivable, Net of Allowance for Doubtful Accounts (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Subtotal	$ 310	$ 279
Allowance for doubtful accounts	(1)	(1)
Accounts receivable, net of allowance for doubtful accounts	309	278
Trade Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Subtotal	298	271
Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Subtotal	$ 12	$ 8

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Millions		Sep. 30, 2017	Dec. 31, 2016
Components of inventories [Abstract]
Raw materials		$ 161	$ 191
Work-in-process		30	35
Finished goods, net		184	190
Materials and supplies, net	[1]	98	97
Total		473	513
Less: Inventories, net - non-current		(14)	(14)
Inventories, net - current		459	499
Inventory on consignment		29	24
Inventory obsolescence reserves		15	17
Reserves for lower of cost or market		$ 17	$ 26
[1]	Consists of processing chemicals, maintenance supplies, and spare parts, which will be consumed directly and indirectly in the production of our products.

Property, Plant and Equipment55

Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Subtotal		$ 1,797		$ 1,797		$ 1,726
Less accumulated depreciation and amortization		(728)		(728)		(634)
Property, plant and equipment, net	[1]	1,069		1,069		1,092
Depreciation expense related to property, plant and equipment		31	$ 30	93	$ 86
Cost of Goods Sold [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense related to property, plant and equipment		30	29	91	84
Selling, General and Administrative Expenses [Member]
Property, Plant and Equipment [Line Items]
Depreciation expense related to property, plant and equipment		1	$ 1	2	$ 2
Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Subtotal		94		94		94
Buildings [Member]
Property, Plant and Equipment [Line Items]
Subtotal		244		244		237
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Subtotal		1,316		1,316		1,275
Construction-in-Progress [Member]
Property, Plant and Equipment [Line Items]
Subtotal		103		103		82
Other [Member]
Property, Plant and Equipment [Line Items]
Subtotal		$ 40		$ 40		$ 38
[1]	Substantially all of these assets are pledged as collateral for our debt. See Note 11.

Mineral Leaseholds, Net (Detail

Mineral Leaseholds, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Summary of minerals leaseholds, net of accumulated depletion [Abstract]
Mineral leaseholds	$ 1,263		$ 1,263		$ 1,257
Less: accumulated depletion	(404)		(404)		(380)
Mineral leaseholds, net	859		859		$ 877
Depletion expense relating to mineral leaseholds recorded in cost of goods sold	$ 8	$ 8	$ 24	$ 26

Intangible Assets, Net (Details

Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Gross cost	$ 367		$ 367		$ 368
Accumulated amortization	(164)		(164)		(145)
Net carrying amount	203		203		223
Amortization expense related to intangible assets	6	$ 6	19	$ 19
Estimated future amortization expense related to intangible assets [Abstract]
Remainder of 2017	6		6
2,018	25		25
2,019	25		25
2,020	25		25
2,021	25		25
Thereafter	97		97
Selling, General and Administrative Expenses [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to intangible assets	6	6	18	18
Cost of Goods Sold [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to intangible assets			1	$ 1
Cost of Goods Sold [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to intangible assets	1	$ 1
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross cost	291		291		291
Accumulated amortization	(129)		(129)		(115)
Net carrying amount	162		162		176
TiO2 Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross cost	32		32		32
Accumulated amortization	(11)		(11)		(9)
Net carrying amount	21		21		23
Internal-use Software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross cost	44		44		45
Accumulated amortization	(24)		(24)		(21)
Net carrying amount	$ 20		$ 20		$ 24

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Summary of accrued liabilities [Abstract]
Employee-related costs and benefits	$ 63	$ 61
Interest	5	35
Sales rebates	19	20
Taxes other than income taxes	11	9
Professional fees and other	33	25
Accrued liabilities	$ 131	$ 150

Debt, Revolving Credit Faciliti

Debt, Revolving Credit Facilities (Details) - USD ($) $ in Millions		Sep. 22, 2017	Sep. 30, 2017	Sep. 30, 2017	Dec. 31, 2016
Line of Credit Facility [Line Items]
Debt issuance costs			$ 47	$ 47	$ 36
Prior Term Loan [Member]
Line of Credit Facility [Line Items]
Original principal	[1]		1,500	1,500
Repayment of outstanding balance		$ 1,500
New Term Loan Facility [Member]
Line of Credit Facility [Line Items]
Original principal	[2]		2,150	2,150
Maximum borrowing capacity		2,150
Debt issuance costs			30	30
Senior Notes due 2025 [Member]
Line of Credit Facility [Line Items]
Original principal		450	450	450
Debt issuance costs			9	9
Wells Fargo Revolver [Member]
Line of Credit Facility [Line Items]
Debt issuance costs			6	$ 6
Wells Fargo Revolver [Member] | Federal Funds Effective Rate [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate				0.50%
Wells Fargo Revolver [Member] | Adjusted LIBOR [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate				1.00%
Debt instrument, term of variable rate				1 month
Wells Fargo Revolver [Member] | Adjusted LIBOR [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Applicable margin added to variable interest rate				1.25%
Wells Fargo Revolver [Member] | Adjusted LIBOR [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Applicable margin added to variable interest rate				1.75%
Wells Fargo Revolver [Member] | Base Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Applicable margin added to variable interest rate				0.25%
Wells Fargo Revolver [Member] | Base Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Applicable margin added to variable interest rate				0.75%
Wells Fargo Revolver [Member] | Letter of Credit [Member]
Line of Credit Facility [Line Items]
Maturity date of revolving credit facility				Sep. 22, 2022
Maximum borrowing capacity		85
Outstanding borrowings on revolvers			19	$ 19
Wells Fargo Revolver [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 550	550	550
Outstanding borrowings on revolvers			0	0
Debt issuance costs			4	4
Amount available to borrow			238	238
UBS Revolver [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Repayment of outstanding balance			150
Unamortized debt issuance costs included in "Gain (loss) on extinguishment of debt"			1	1
Remaining unamortized original debt issuance costs amortized over life of Well Fargo Revolver			2	2
Debt issuance costs			$ 2	$ 2
[1]	Average effective interest rate of 5.2% and 5.1% during the three and nine months ended September 30, 2017, respectively, and 4.9% each during the three and nine months ended September 30, 2016.
[2]	Average effective interest rate of 4.5% during each of the three and nine months ended September 30, 2017.

Debt, Components of Long-Term D

Debt, Components of Long-Term Debt, Net of Unamortized Discount and Debt Issuance Costs (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 22, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Long-term debt		$ 3,187		$ 3,187			$ 2,940
Less: Long-term debt due within one year		(11)		(11)			(16)
Debt issuance costs		(47)		(47)			(36)
Long-term debt, net		3,129		3,129			2,888
Prior Term Loan [Member]
Debt Instrument [Line Items]
Original principal	[1]	1,500		$ 1,500
Annual interest rate	[1]			Variable
Maturity date	[1]			Mar. 20, 2020
Long-term debt	[1]	$ 0		$ 0			1,441
Average effective interest rate		5.20%	4.90%	5.10%	4.90%
New Term Loan Facility [Member]
Debt Instrument [Line Items]
Original principal	[2]	$ 2,150		$ 2,150
Annual interest rate	[2]			Variable
Maturity date	[2]			Sep. 22, 2024
Long-term debt	[2]	2,136		$ 2,136			0
Debt issuance costs		$ (30)		$ (30)
Average effective interest rate		4.50%		4.50%
Senior Notes due 2020 [Member]
Debt Instrument [Line Items]
Original principal		$ 900		$ 900
Annual interest rate		6.375%		6.375%
Maturity date				Aug. 15, 2020
Long-term debt		$ 0		$ 0			896
Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Original principal		$ 600		$ 600
Annual interest rate		7.50%		7.50%
Maturity date				Mar. 15, 2022
Long-term debt		$ 584		$ 584			584
Debt issuance costs		(8)		(8)			(10)
Senior Notes due 2025 [Member]
Debt Instrument [Line Items]
Original principal		$ 450		$ 450		$ 450
Annual interest rate		5.75%		5.75%
Maturity date				Sep. 22, 2025
Long-term debt		$ 450		$ 450			0
Debt issuance costs		(9)		(9)
Lease Financing [Member]
Debt Instrument [Line Items]
Long-term debt		$ 17		$ 17			$ 19
[1]	Average effective interest rate of 5.2% and 5.1% during the three and nine months ended September 30, 2017, respectively, and 4.9% each during the three and nine months ended September 30, 2016.
[2]	Average effective interest rate of 4.5% during each of the three and nine months ended September 30, 2017.

Debt, Scheduled Maturities of L

Debt, Scheduled Maturities of Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Scheduled maturities of long-term debt [Abstract]
2,017	$ 0
2,018	17
2,019	22
2,020	22
2,021	22
Thereafter	3,118
Total	3,201
Remaining accretion associated with the New Term Loans	(14)
Total borrowings	$ 3,187	$ 2,940

Debt, Term Loan and Senior Note

Debt, Term Loan and Senior Notes (Details) - USD ($) $ in Millions		Sep. 25, 2017	Sep. 22, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Mar. 19, 2015	Apr. 23, 2014	Sep. 17, 2013
Debt Instrument [Line Items]
Unamortized discount				$ 14		$ 14
Debt issuance costs				47		47		$ 36
Gain (loss) on extinguishment of debt				(28)	$ 0	(28)	$ 4
Cash and cash equivalents				1,058	202	1,058	202	248	$ 229
Cash payment made in connection with redemption of debt						2,342	27
Restricted cash				653		653		3
New Term Loan Facility [Member]
Debt Instrument [Line Items]
Debt issuance costs				30		30
Original principal	[1]			2,150		2,150
Interest expense accrued				2	0	2	0
Prior Term Loan [Member]
Debt Instrument [Line Items]
Principal repayment			$ 1,500
Original principal	[2]			1,500		1,500
Interest expense accrued				16	17	49	50
Senior Notes due 2020 [Member]
Debt Instrument [Line Items]
Original principal				$ 900		$ 900
Interest rate				6.375%		6.375%
Interest expense accrued				$ 13	14	$ 41	43
Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Debt issuance costs				8		8		10
Original principal				$ 600		$ 600
Interest rate				7.50%		7.50%
Interest expense accrued				$ 11	11	$ 33	33
Senior Notes Due 2025 [Member]
Debt Instrument [Line Items]
Debt issuance costs				9		9
Original principal			450	$ 450		$ 450
Interest rate				5.75%		5.75%
Interest expense accrued				$ 1	0	$ 1	0
Secured Debt [Member] | Term Loan Credit Facility [Member]
Debt Instrument [Line Items]
Debt issuance costs				30		30
Secured Debt [Member] | New Term Loan Facility [Member]
Debt Instrument [Line Items]
Unamortized discount				11		11
Unamortized original debt discount and issuance costs included in "Gain (loss) on extinguishment of debt"				4		4
Unamortized original debt discount and issuance costs amortized over life of Term Loan Facility				16		16
Debt issuance costs				17		$ 17
Original principal			1,500
Secured Debt [Member] | New Term Loan Facility [Member] | Adjusted LIBOR [Member]
Debt Instrument [Line Items]
Basis spread on variable rate						3.00%
Secured Debt [Member] | Prior Term Loan [Member]
Debt Instrument [Line Items]
Principal repayment			1,400
Unamortized original debt discount and issuance costs included in "Gain (loss) on extinguishment of debt"				1		$ 1
Debt issuance costs				13		13		17
Original principal											$ 1,500
Secured Debt [Member] | Blocked Term Loan [Member]
Debt Instrument [Line Items]
Original principal			650
Restricted cash				650		650
Senior Notes [Member] | Senior Notes due 2020 [Member]
Debt Instrument [Line Items]
Unamortized original debt discount and issuance costs amortized over life of Term Loan Facility				8		8
Original principal		$ 900										$ 900
Interest rate		6.375%										6.375%
Face value of notes repurchased					4		$ 4
Redemption price of debt repurchased							77.00%
Gain (loss) on extinguishment of debt						(22)	$ 1
Debt issuance costs, call premium		$ 14
Debt instrument, outstanding balance redeemed		896
Cash payment made in connection with redemption of debt		917
Interest expense accrued		$ 7
Senior Notes [Member] | Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Principal repayment				0		0
Debt issuance costs				$ 8		$ 8		$ 10
Original principal										$ 600
Interest rate										7.50%
Face value of notes repurchased					$ 16		$ 16
Redemption price of debt repurchased							76.00%
Gain (loss) on extinguishment of debt							$ 3
Senior Notes [Member] | Senior Notes Due 2025 [Member]
Debt Instrument [Line Items]
Debt issuance costs			$ 9
Maturity date			Oct. 1, 2025
[1]	Average effective interest rate of 4.5% during each of the three and nine months ended September 30, 2017.
[2]	Average effective interest rate of 5.2% and 5.1% during the three and nine months ended September 30, 2017, respectively, and 4.9% each during the three and nine months ended September 30, 2016.

Debt, Lease Financing, Fair Val

Debt, Lease Financing, Fair Value and Debt Covenants (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Secured Debt [Member] | New Term Loan Facility [Member] | Level 1 [Member]
Debt Instrument [Line Items]
Fair value of debt instrument	$ 2,200		$ 2,200		$ 2,200
Senior Notes [Member] | Senior Notes due 2022 [Member] | Level 1 [Member]
Debt Instrument [Line Items]
Fair value of debt instrument	616		616		544
Senior Notes [Member] | Senior Notes Due 2025 [Member] | Level 1 [Member]
Debt Instrument [Line Items]
Fair value of debt instrument	$ 461		$ 461
Lease Financing [Member]
Debt Instrument [Line Items]
Weighted average interest rate	14.00%		14.00%
Assets recorded under capital lease obligations	$ 21		$ 21		7
Accumulated amortization related to assets recorded under capital lease obligations	7		7		$ 6
Lease Financing [Member] | Maximum [Member]
Debt Instrument [Line Items]
Payments on capital leases	$ 1	$ 1	$ 1	$ 1

Debt, Summary of Interest and D

Debt, Summary of Interest and Debt Expense, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Summary of interest and debt expense, net [Abstract]
Amortization of deferred debt issuance costs and discounts on debt	$ 3	$ 3	$ 9	$ 8
Other	2	1	7	6
Capitalized interest	(1)	0	(2)	(2)
Total interest and debt expense, net	47	46	140	138
Deferred debt issuance costs	47		47		$ 36
Prior Term Loan [Member]
Summary of interest and debt expense, net [Abstract]
Interest on debt	16	17	49	50
New Term Loan Facility [Member]
Summary of interest and debt expense, net [Abstract]
Interest on debt	2	0	2	0
Deferred debt issuance costs	30		30
Senior Notes due 2020 [Member]
Summary of interest and debt expense, net [Abstract]
Interest on debt	13	14	41	43
Senior Notes due 2022 [Member]
Summary of interest and debt expense, net [Abstract]
Interest on debt	11	11	33	33
Deferred debt issuance costs	8		8		$ 10
Senior Notes due 2025 [Member]
Summary of interest and debt expense, net [Abstract]
Interest on debt	1	$ 0	1	$ 0
Deferred debt issuance costs	9		9
Wells Fargo Revolver [Member]
Summary of interest and debt expense, net [Abstract]
Deferred debt issuance costs	$ 6		$ 6

Asset Retirement Obligations (D

Asset Retirement Obligations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Activity related to asset retirement obligations [Roll Forward]
Beginning balance	$ 80	$ 78	$ 76	$ 81
Additions	1	0	1	1
Accretion expense	2	1	4	4
Remeasurement/translation	0	3	4	5
Changes in estimates, including cost and timing of cash flows	0	0	0	(9)
Settlements/payments	(1)	0	(3)	0
Ending balance	82	$ 82	82	82
Asset retirement obligations [Abstract]
Asset retirement obligations, current	4		4		$ 3
Asset retirement obligations, noncurrent	$ 78		$ 78		$ 73
TiO2 Pigment Facility [Member]
Asset Retirement Obligation [Line Items]
Additional lease term			25 years
Reduction in assets retirements obligations				$ (10)

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2017USD ($)
Purchase commitments, fiscal year maturity [Abstract]
Remainder of 2017	$ 72
2,018	82
2,019	57
2,020	41
2,021	29
Thereafter	118
Loss Contingencies [Line Items]
Loss contingency	43
Letters of Credit [Member] | Wells Fargo Revolver [Member]
Loss Contingencies [Line Items]
Loss contingency	19
Letters of Credit [Member] | UBS Revolver [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss contingency	1
Bank Guarantees [Member] | ABSA [Member]
Loss Contingencies [Line Items]
Loss contingency	18
Bank Guarantees [Member] | Standard Bank [Member]
Loss Contingencies [Line Items]
Loss contingency	5
Performance Bonds [Member] | Westpac Banking Corporation [Member]
Loss Contingencies [Line Items]
Loss contingency	$ 1

Shareholders' Equity, Changes i

Shareholders' Equity, Changes in Outstanding Shares (Details)	9 Months Ended
	Sep. 30, 2017shares
Class A [Member]
Changes in outstanding shares [Roll Forward]
Balance, beginning of period (in shares)	65,165,672
Shares issued for share-based compensation (in shares)	3,034,771
Shares issued upon warrants exercised (in shares)	964,897
Shares issued upon options exercised (in shares)	45,753
Shares issued cancelled for share-based compensation (in shares)	(619,999)
Balance, end of period (in shares)	68,591,094
Class B [Member]
Changes in outstanding shares [Roll Forward]
Balance, beginning of period (in shares)	51,154,280
Balance, end of period (in shares)	51,154,280

Shareholders' Equity, Warrants

Shareholders' Equity, Warrants (Details) - $ / shares	9 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Class of Warrant or Right [Line Items]
Term of warrants from date of issuance	7 years
Expiry date of warrants	Feb. 14, 2018
Series A Warrants [Member]
Class of Warrant or Right [Line Items]
Cash receivable per share under warrant (in dollars per share)	$ 12.50
Exercise price of warrants (in dollars per share)	$ 51.21
Warrants outstanding (in shares)	159,530	239,306
Series A Warrants [Member] | Class A [Member]
Class of Warrant or Right [Line Items]
Number of shares warrants are entitled to purchase (in shares)	6.02
Series B Warrants [Member]
Class of Warrant or Right [Line Items]
Cash receivable per share under warrant (in dollars per share)	$ 12.50
Exercise price of warrants (in dollars per share)	$ 56.51
Warrants outstanding (in shares)	167,377	323,915
Series B Warrants [Member] | Class A [Member]
Class of Warrant or Right [Line Items]
Number of shares warrants are entitled to purchase (in shares)	6.03

Shareholders' Equity, Dividends

Shareholders' Equity, Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Sep. 30, 2017
Shareholders' Equity [Abstract]
Dividend per share (in dollars per share)	$ 0.045	$ 0.045	$ 0.045	$ 0.045	$ 0.045	$ 0.250
Total dividend	$ 5	$ 6	$ 6	$ 5	$ 5	$ 30	$ 17
Record date (close of business)	Aug. 21, 2017	May 15, 2017	Mar. 6, 2017	Aug. 17, 2016	May 16, 2016	Mar. 4, 2016

Shareholders' Equity, Accumulat

Shareholders' Equity, Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Changes in accumulated other comprehensive income (loss) by component [Roll Forward]
Balance			$ 1,153
Other comprehensive income (loss)	$ (26)	$ 29	16	$ 71
Amounts reclassified from accumulated other comprehensive income (loss)	6	(1)	7
Balance	906		906
Accumulated Other Comprehensive Loss [Member]
Changes in accumulated other comprehensive income (loss) by component [Roll Forward]
Balance	(454)	(555)	(497)	(598)
Balance	(474)	(527)	(474)	(527)
Cumulative Translation Adjustment [Member]
Changes in accumulated other comprehensive income (loss) by component [Roll Forward]
Balance	(363)	(456)	(408)	(496)
Other comprehensive income (loss)	(26)	51	19	91
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Balance	(389)	(405)	(389)	(405)
Pension Liability Adjustment [Member]
Changes in accumulated other comprehensive income (loss) by component [Roll Forward]
Balance	(91)	(101)	(92)	(102)
Other comprehensive income (loss)	0	(21)	0	(21)
Amounts reclassified from accumulated other comprehensive income (loss)	6	(1)	7
Balance	(85)	(123)	(85)	(123)
Unrealized Gains (Losses) on Derivatives [Member]
Changes in accumulated other comprehensive income (loss) by component [Roll Forward]
Balance	0	2	3	0
Other comprehensive income (loss)	0	(1)	(3)	1
Amounts reclassified from accumulated other comprehensive income (loss)	0	0	0
Balance	$ 0	$ 1	$ 0	$ 1

Noncontrolling Interest (Detail

Noncontrolling Interest (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Noncontrolling Interest [Line Items]
Percentage of exchange interest in additional shares			3.20%
Noncontrolling interest activity [Roll Forward]
Beginning balance	$ 162	$ 126	$ 144	$ 112
Net income (loss) attributable to noncontrolling interest	6	(2)	11	(1)
Effect of exchange rate changes	(10)	18	3	31
Ending balance	$ 158	$ 142	$ 158	$ 142
Tronox KZN Sands (Pty) Ltd. [Member]
Noncontrolling Interest [Line Items]
Retained ownership interest	26.00%		26.00%
Tronox Mineral Sands (Pty) Ltd. [Member]
Noncontrolling Interest [Line Items]
Retained ownership interest	26.00%		26.00%
Other Non-Operating Subsidiaries [Member]
Noncontrolling Interest [Line Items]
Retained ownership interest	26.00%		26.00%

Share-Based Compensation, Summa

Share-Based Compensation, Summary of Compensation Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	$ 5	$ 8	$ 26	$ 18
Restricted Shares and Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	5	7	25	15
Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	0	1	0	2
T-Bucks Employee Participation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	$ 0	$ 0	$ 1	$ 1

Share-Based Compensation, Trono

Share-Based Compensation, Tronox Limited Management Equity Incentive Plan (Details) - Tronox Limited Management Equity Incentive Plan [Member] - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Restricted Shares [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Outstanding, beginning of period (in shares)			284,400
Vested (in shares)			(107,928)
Outstanding, end of period (in shares)	176,472		176,472		284,400
Expected to vest, end of period (in shares)	176,472		176,472
Restricted Shares and Restricted Share Units ("RSUs"), Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning of period (in dollars per share)			$ 6.09
Vested (in dollars per share)			8
Outstanding, end of period (in dollars per share)	$ 4.92		4.92		$ 6.09
Expected to vest, end of period (in dollars per share)	$ 4.92		$ 4.92
Weighted average period of recognition for unrecognized compensation expense			1 year 1 month 6 days
Total fair value of restricted shares and RSUs vested			$ 1
Restricted Shares [Member] | Maximum [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Weighted Average Grant Date Fair Value [Abstract]
Unrecognized compensation expense related to nonvested restricted shares and nonvested RSUs	$ 1		$ 1
Restricted Share Units (RSUs) [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Outstanding, beginning of period (in shares)			5,587,331
Granted (in shares)			2,944,267
Vested (in shares)			(2,378,609)
Forfeited (in shares)			(604,918)
Outstanding, end of period (in shares)	5,548,071		5,548,071		5,587,331
Expected to vest, end of period (in shares)	5,797,277		5,797,277
Restricted Shares and Restricted Share Units ("RSUs"), Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning of period (in dollars per share)			$ 7.19
Granted (in dollars per share)			17.19	$ 4.04
Vested (in dollars per share)			9.52
Forfeited (in dollars per share)			9.81
Outstanding, end of period (in dollars per share)	$ 11.22		11.22		$ 7.19
Expected to vest, end of period (in dollars per share)	$ 9.83		$ 9.83
Unrecognized compensation expense related to nonvested restricted shares and nonvested RSUs	$ 35		$ 35
Weighted average period of recognition for unrecognized compensation expense			2 years
Total fair value of restricted shares and RSUs vested			$ 23
Restricted Share Units (RSUs) [Member] | Executive Officers and Managers [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			1,255,697
Restricted Share Units (RSUs), Time-Based Awards [Member] | Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			1 year
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			100,160
Restricted Share Units (RSUs), Time-Based Awards [Member] | Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			3 years
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			12,869
Restricted Share Units (RSUs), Time-Based Awards [Member] | Tranche Three [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			1,075
Restricted Share Units (RSUs), Time-Based Awards [Member] | Tranche Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			9 months
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			14,053
Restricted Share Units (RSUs), Performance-Based Awards [Member] | Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			3 years
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			1,145,933
Restricted Share Units (RSUs), Performance-Based Awards [Member] | Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period			40 months
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			12,865
Restricted Share Units (RSUs), Performance-Based Awards [Member] | Tranche Three [Member]
Restricted Shares and Restricted Share Units ("RSUs"), Number of Shares [Roll Forward]
Granted (in shares)			786,639
Options [Member]
Options, Number of Options [Roll Forward]
Outstanding, beginning of period (in shares)			1,970,481
Exercised (in shares)		0	(45,753)	0
Forfeited (in shares)			(4,273)
Expired (in shares)			(93,101)
Outstanding, end of period (in shares)	1,827,354		1,827,354		1,970,481
Expected to vest, end of period (in shares)	789		789
Exercisable, end of period (in shares)	1,826,560		1,826,560
Options, Weighted Average Exercise Price [Abstract]
Outstanding, beginning of period (in dollars per share)			$ 21.19
Exercised (in dollars per share)			19.32
Forfeited (in dollars per share)			21.98
Expired (in dollars per share)			21.58
Outstanding, end of period (in dollars per share)	$ 21.21		21.21		$ 21.19
Expected to vest, end of period (in dollars per share)	22.69		22.69
Exercisable, end of period (in dollars per share)	$ 21.21		$ 21.21
Options, Additional Disclosures [Abstract]
Weighted average contractual life, outstanding			4 years 7 months 13 days		6 years 4 months 17 days
Weighted average contractual life, expected to vest			1 year 3 months 7 days
Weighted average contractual life, exercisable			4 years 7 months 10 days
Intrinsic value, outstanding, beginning of period			$ 0
Intrinsic value, outstanding, end of period	$ 2		2		$ 0
Intrinsic value, expected to vest, end of period	0		0
Intrinsic value, exercisable, end of period	2		2
Intrinsic value of options exercised		$ 0		$ 0
Cash received from exercise of stock options	1	$ 0	$ 1	$ 0
Options issued (in shares)			0
Unrecognized compensation expense related to options, adjusted for estimated forfeitures	0		$ 0
Options [Member] | Maximum [Member]
Options, Additional Disclosures [Abstract]
Intrinsic value of options exercised	$ 1		$ 1

Share-Based Compensation, T-Buc

Share-Based Compensation, T-Bucks EPP and Long-Term Incentive Plan (Details) ZAR in Millions, $ in Millions	1 Months Ended	12 Months Ended
	Jun. 30, 2017shares	Dec. 31, 2012USD ($)	Dec. 31, 2012ZAR	Sep. 30, 2017USD ($)	Dec. 31, 2016USD ($)
T-Bucks Employee Participation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount funded to the trust		$ 15	ZAR 124
Shares sold by the Trust (in shares) | shares	546,403
Long-term Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Long term incentive plan liability | $				$ 0	$ 0

Pension and Other Postretirem75

Pension and Other Postretirement Healthcare Benefits (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net periodic cost [Abstract]
Service cost	$ 0	$ 0	$ 0	$ 0
Interest cost	3	5	11	15
Expected return on plan assets	(4)	(5)	(11)	(15)
Net amortization of actuarial loss and prior service credit	1	0	2	1
Curtailment gain (loss)	0	(1)	0	(1)
Total net periodic cost	$ 0	(1)	$ 2	0
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Tax Status [Extensible List]	us-gaap:QualifiedPlanMember		us-gaap:QualifiedPlanMember
Actuarial losses and prior service costs	$ (5)
Postretirement Healthcare Plans [Member]
Net periodic cost [Abstract]
Total net periodic cost			$ 1	1
Postretirement Healthcare Plans [Member] | Maximum [Member]
Net periodic cost [Abstract]
Total net periodic cost	1	1
Multiemployer Plans, Pension [Member] | NETHERLANDS [Member]
Multiemployer Plans [Line Items]
Employer contribution amount	$ 1	$ 1	$ 3	$ 3

Related Parties (Details)

Related Parties (Details) - Exxaro [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Related Party Transaction [Line Items]
Amount to related party capitalized in property, plant and equipment	$ 1	$ 0
Maximum [Member]
Related Party Transaction [Line Items]
Selling, general and administrative expenses to related party transaction	1	$ 1	$ 1	$ 1
Amount to related party capitalized in property, plant and equipment			2	$ 1
Related party payables	$ 1		$ 1		$ 1

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Segment Reporting Information [Line Items]
Net sales (TiO2)	$ 435	$ 339	$ 1,234	$ 957
Income (loss) from operations	51	0	78	(57)
Interest and debt expense, net	(47)	(46)	(140)	(138)
Gain on extinguishment of debt	(28)	0	(28)	4
Other income (expense), net	12	(10)	5	(22)
Income (loss) from continuing operations before income taxes	(12)	(56)	(85)	(213)
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Income (loss) from operations	(24)	(17)	(90)	(45)
TiO2 Segment [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales (TiO2)	435	339	1,234	957
Income (loss) from operations	$ 75	$ 17	$ 168	$ (12)